Medizinische Universität Graz - Research portal
Fahrleitner-Pammer Astrid |
** = Publications listed in SCI/SSCI/Pubmed
2024
Full paper/article (Journal)
** Dimai, HP; Muschitz, C; Amrein, K; Bauer, R; Cejka, D; Gasser, RW; Gruber, R; Haschka, J; Hasenöhrl, T; Kainberger, F; Kerschan-Schindl, K; Kocijan, R; König, J; Kroissenbrunner, N; Kuchler, U; Oberforcher, C; Ott, J; Pfeiler, G; Pietschmann, P; Puchwein, P; Schmidt-Ilsinger, A; Zwick, RH; Fahrleitner-Pammer, A
Osteoporosis-Definition, risk assessment, diagnosis, prevention and treatment (update 2024): Guidelines of the Austrian Society for Bone and Mineral Research
WIEN KLIN WOCHENSCHR. 2024; 136(SUPPL 16): 599-668.
Doi: 10.1007/s00508-024-02441-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Fink, A; Puchwein, P; Fahrleitner-Pammer, A; Eder-Halbedl, M; Bernhardt, GA
Increased Early Postoperative Complication Rate after Osteoporotic Hip Fracture in Patients with Low 25 (OH) Vitamin D Levels.
Nutrients. 2024; 16(12): 1917
Doi: 10.3390/nu16121917
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tmava-Berisha, A; Fahrleitner-Pammer, A; Stross, T; Geiger, S; Geiger, C; Fellendorf, F; Scherkl, M; Finner, A; Holl, A; Dalkner, N; Reininghaus, E; Amrein, K
Cognitive Function in Individuals with Chronic Hypoparathyroidism - A Prospective Observational Study.
J Clin Endocrinol Metab. 2024;
Doi: 10.1210/clinem/dgae800
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Schmid, J; Kolesnik, E; Schwegel, N; Späth, J; Kattnig, L; Riepl, H; Zach, D; Santner, V; Höller, V; Pilz, S; Tomaschitz, A; Fuchsjäger, M; Fahrleitner-Pammer, A; Dimai, HP; Obermayer-Pietsch, B; Fruhwald, F; Scherr, D; Zirlik, A; von, Lewinski, D; Ablasser, K
Prevalence and prognostic impact of bone disease in chronic heart failure with reduced ejection fraction.
ESC Heart Fail. 2024; 11(3):1730-1738
Doi: 10.1002/ehf2.14741
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Gatineau, G; DeGruttola, M; Nguyen, G; Hind, K; Davies, M; Kuzma, M; Payer, J; Guglielmi, G; Fahrleitner, A; Krueger, DC; Binkley, N; Hans, D
Artificial Intelligence-Based, Automatic and Explainable Bone Fragility Detection from X-ray: a Multi-National Cohort Study
J BONE MINER RES. 2024; 39: 43-43.
[Poster]
Web of Science
** Gatineau, G; Nguyen, G; Degruttola, M; Hind, K; Kuzma, M; Payer, J; Guglielmi, G; Fahrleitner-Pammer, A; Hans, D
EXTERNAL VALIDATION OF AI-DRIVEN BONE FRAGILITY DETECTION IN RADIOGRAPHS FROM MULTINATIONAL COHORTS
AGING CLIN EXP RES. 2024; 36: S18-S19.
[Poster]
Web of Science
2023
Full paper/article (Journal)
** Herteux, J; Geiger, SJ; Starchl, C; Windisch, J; Lerchl, T; Tmava-Berisha, A; Wünsch, G; Eller, K; Fahrleitner-Pammer, A; Amrein, K
Hospitalizations, emergency room visits and causes of death in 198 patients with permanent hypoparathyroidism: a retrospective Austrian study (2005-2022).
Endocr Connect. 2023; 12(5): e220533
Doi: 10.1530/EC-22-0533
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moissl, AP; Lorkowski, S; Meinitzer, A; Pilz, S; Scharnagl, H; Delgado, GE; Kleber, ME; Krämer, BK; Pieske, B; Grübler, MR; Brussee, H; von, Lewinski, D; Toplak, H; Fahrleitner-Pammer, A; März, W; Tomaschitz, A
Association of branched-chain amino acids with mortality-the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
iScience. 2023; 26(4): 106459
Doi: 10.1016/j.isci.2023.106459
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Cejka, D; Wakolbinger-Habel, R; Zitt, E; Fahrleitner-Pammer, A; Amrein, K; Dimai, HP; Muschitz, C
[Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].
Wien Med Wochenschr. 2023; 173(13-14):299-318
Doi: 10.1007/s10354-022-00989-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Moissl, A; Lorkowski, S; Meinitzer, A; Pilz, S; Scharnagl, H; Delgado, G; Kleber, M; Krämer, B; Pieske, B; Grübler, M; Brussee, H; Von Lewinski, D; Toplak, H; Fahrleitner-Pammer, A; März, W; Tomaschitz, A
HEAT FAILURE WITH PRESERVED EJECTION FRACTION. ASSOCIATION OF BRANCHED-CHAIN AMINO ACIDS WITH MORTALITY RISK IN THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH (LURIC) STUDY
ATHEROSCLEROSIS. 2023; 379: S140-S140.-91st Annual Meeting of the European-Atherosclerosis-Society (EAS); MAY 21-24, 2023; Mannheim, GERMANY.
[Poster]
Web of Science
2022
Full paper/article (Journal)
** Dimai, HP; Johansson, H; Harvey, NC; Lorentzon, M; Liu, E; Vandenput, L; Fahrleitner-Pammer, A; Pietschmann, P; Muschitz, C; McCloskey, EV; Kanis, JA
Osteoporosis treatment in Austria-assessment of FRAX-based intervention thresholds for high and very high fracture risk.
Arch Osteoporos. 2022; 17(1): 141
Doi: 10.1007/s11657-022-01175-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Langdahl, B; Hofbauer, LC; Ferrari, S; Wang, ZX; Fahrleitner-Pammer, A; Gielen, E; Lakatos, P; Czerwinski, E; Gimeno, EJ; Timoshanko, J; Oates, M; Libanati, C
Romosozumab efficacy and safety in European patients enrolled in the FRAME trial
OSTEOPOROSIS INT. 2022;
Doi: 10.1007/s00198-022-06544-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Malle, O; Bergthaler, M; Krisper, P; Amrein, K; Dimai, HP; Kirsch, AH; Rosenkranz, AR; Pieber, T; Obermayer-Pietsch, B; Fahrleitner-Pammer, A
Usefulness of the trabecular bone score in maintenance dialysis patients : A single center observational study.
Wien Klin Wochenschr. 2022; 134(11-12):442-448
Doi: 10.1007/s00508-022-02011-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Case Report
** Dimai, HP; Fahrleitner-Pammer, A
Osteoporosis and Fragility Fractures: currently available pharmacological options and future directions.
Best Pract Res Clin Rheumatol. 2022; 36(3):101780
Doi: 10.1016/j.berh.2022.101780
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Dimai, HP; Reichardt, B; Zitt, E; Concin, H; Malle, O; Fahrleitner-Pammer, A; Brozek, W
Thirty Years of Hip Fracture Incidence in Austria; is the Worst Over?
J BONE MINER RES. 2022; 37: 139-140.-Annual Meeting of the American-Society-for-Bone-and-Mineral-Research (ASBMR); OCT 01-04, 2021; San Diego, CA.
[Poster]
Web of Science
Abstract (Proceedings)
** Dimai, HP; Reichardt, B; Zitt, E; Concin, H; Malle, O; Fahrleitner-Pammer, A; Svedbom, A; Brozek, W
Thirty years of hip fracture incidence in Austria: is the worst over?
Osteoporos Int. 2022; 33(1):97-104
Doi: 10.1007/s00198-021-06086-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Full paper/article (Journal)
** Malle, O; Borgstroem, F; Fahrleitner-Pammer, A; Svedbom, A; Dimai, SV; Dimai, HP
Mind the gap: Incidence of osteoporosis treatment after an osteoporotic fracture - results of the Austrian branch of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS).
Bone. 2021; 142:115071
Doi: 10.1016/j.bone.2019.115071
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Malle, O; Maurer, D; Wagner, D; Schnedl, C; Amrein, S; Pieber, T; Fahrleitner-Pammer, A; Dimai, HP; Amrein, K
Morphometric parameters of muscle and bone in critically ill patients : Post hoc analysis of the VITdAL-ICU trial.
Wien Klin Wochenschr. 2021; 133(11-12):529-535
Doi: 10.1007/s00508-020-01736-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Bytyqi, K; Baumann, PM; Hochfellner, D; Aberer, F; Simic, A; Treiber, G; Pottler, T; Holl, B; Fahrleitner-Pammer, A; Beck, P; Mader, J
Feasibility to use a continuous glucose monitoring system to manage diabetes during hospitalisation
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):211-212.-49. Jahrestagung ÖDG; NOV 18-20; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Dimai, HP; Reichardt, B; Zitt, E; Concin, H; Malle, O; Fahrleitner-Pammer, A; Svedbom, A; Brozek, W
THIRTY YEARS OF HIP FRACTURE IN AUSTRIA; IS THE WORST OVER?
OSTEOPOROSIS INT. 2021; 32(SUPPL 1):S370-S371.
[Poster]
Web of Science
** Hochfellner, DA; Baumann, PM; Aberer, F; Simic, A; Bytyqi, L; Pottler, T; Holl, B; Fahrleitner-Pammer, A; Pieber, TR; Beck, P; Mader, J
Basal-bolus Insulin Therapy through an electronic Decision Support System for stationary glycemic Control with Insulin degludec
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):209-209.
[Poster]
Web of Science
** Langdahl, B; Hofbauer, LC; Ferrari, SL; Wang, Z; Fahrleitner-Pammer, A; Gielen, E; Lakatos, P; Czerwinski, E; Jodar-Gimeno, E; Timoshanko, J; Oates, M; Libanati, C
ROMOSOZUMAB EFFICACY AND SAFETY IN EUROPEAN PATIENTS: A SUBANALYSIS OF THE PHASE 3, RANDOMISED FRAME STUDY
OSTEOPOROSIS INT. 2021; 32(SUPPL 1): S45-S46.
Web of Science
2020
Full paper/article (Journal)
** Body, JJ; Marin, F; Kendler, DL; Zerbini, CAF; López-Romero, P; Möricke, R; Casado, E; Fahrleitner-Pammer, A; Stepan, JJ; Lespessailles, E; Minisola, S; Geusens, P
Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial.
Osteoporos Int. 2020; 31(10):1935-1942
Doi: 10.1007/s00198-020-05463-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Geusens, P; Kendler, DL; Fahrleitner-Pammer, A; López-Romero, P; Marin, F
Distribution of Prevalent and Incident Vertebral Fractures and Their Association with Bone Mineral Density in Postmenopausal Women in the Teriparatide Versus Risedronate VERO Clinical Trial.
Calcif Tissue Int. 2020; 106(6):646-654
Doi: 10.1007/s00223-020-00683-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Haberl, HC; Pottler, T; Hochfellner, D; Aberer, F; Ziko, H; Simic, A; Bytyqi, L; Baumann, P; Samonigg, J; Beck, P; Fahrleitner-Pammer, A; Mader, JK
Evaluation of the Sensor Performance of a blinded, professional continuous Glucose Measurement System in hospitalized Female Patients with Type 2 Diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S360-S360.-Jahrestagung der österreichischen Diabetesgesellschaft ;
[Poster]
Web of Science
** Haberl, HC; Pottler, T; Hochfellner, DA; Aberer, F; Ziko, H; Bytyqi, L; Baumann, P; Samonigg, J; Beck, P; Fahrleitner-Pammer, A; Mader, JK
Assessment of sensor performance of a blinded professional continuous glucose monitoring system in hospitalised patients with type 2 diabetes.
DIABETOLOGIA. 2020; 63(SUPPL 1):S348-S349.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK.
[Poster]
Web of Science
** Malle, OM; Fahrleitner-Pammer, AF; Dimai, HP
IMPACT OF OSTEOPOROSIS TREATMENT ON QUALITY OF LIFE (QOL) AFTER FRAGILITY FRACTURE
OSTEOPOROSIS INT. 2020; 31(SUPPL 1):S429-S429.
[Poster]
Web of Science
** Verheyen, N; Schmid, J; Kolesnik, E; Bencic, D; Kattnig, L; Scherr, D; Manninger, M; Fruhwald, F; Obermayer-Pietsch, B; Fahrleitner-Pammer, A; Zirlik, A; von Lewinski, D; Ablasser, K
Prevalence and determinants of bone disease in patients with chronic heart failure-a prospective cohort study.
WIEN KLIN WOCHENSCHR. 2020; 132: S234-S235.
[Poster]
Web of Science
FullText
2019
Full paper/article (Journal)
** Bilezikian, JP; Lin, CJF; Brown, JP; Wang, AT; Yin, X; Ebeling, PR; Fahrleitner-Pammer, A; Franek, E; Gilchrist, N; Miller, PD; Simon, JA; Valter, I; Zerbini, CAF; Libanati, C; Chines, A
Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.
Osteoporos Int. 2019; 30(9): 1855-1864.
Doi: 10.1007/s00198-019-05020-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dimai, HP; Ljuhar, R; Ljuhar, D; Norman, B; Nehrer, S; Kurth, A; Fahrleitner-Pammer, A
Assessing the effects of long-term osteoporosis treatment by using conventional spine radiographs: results from a pilot study in a sub-cohort of a large randomized controlled trial.
Skeletal Radiol. 2019; 48(7):1023-1032
Doi: 10.1007/s00256-018-3118-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Minisola, S; Marin, F; Kendler, DL; Geusens, P; Zerbini, CAF; Russo, LA; Casado, E; Fahrleitner-Pammer, A; Stepan, JJ; Lespessailles, E; Moericke, R; Bagur, A; Lakatos, P; López-Romero, P; Body, JJ
Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.
Arch Osteoporos. 2019; 14(1):10-10
Doi: 10.1007/s11657-019-0561-x
Web of Science
PubMed
FullText
FullText_MUG
** Shboul, M; Roschger, P; Ganger, R; Paschalis, L; Rokidi, S; Zandieh, S; Behunova, J; Muschitz, C; Fahrleitner-Pammer, A; Ng, AYJ; Tohari, S; Venkatesh, B; Bonnard, C; Reversade, B; Klaushofer, K; Al Kaissi, A
Bone matrix hypermineralization associated with low bone turnover in a case of Nasu-Hakola disease.
Bone. 2019; 123:48-55
Doi: 10.1016/j.bone.2018.10.008
Web of Science
PubMed
FullText
FullText_MUG
** Steiner, B; Dimai, HP; Steiner, H; Cirar, S; Fahrleitner-Pammer, A
Prescreening for Osteoporosis With Quantitative Ultrasound in Postmenopausal White Women.
J Ultrasound Med. 2019; 38(6):1553-1559
Doi: 10.1002/jum.14844
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Bencic, D; Schmid, J; Fuchsjager, M; Fahrleitner-Pammer, A; Obermayer-Pietsch, B; Pieber, T; Kolesnik, E; Zirlik, A; Fruhwald, F; von Lewinski, D; Ablasser, K; Verheyen, N; Tomaschitz, A; Scherr, D
Association between plasma sodium and bone disease in patients with chronic heart failure: a prospective cohort study
J BONE MINER RES. 2019; 34: 357-357.-Annual Meeting of the American-Society-for-Bone-and Mineral Research; SEP 20-23, 2019; Orlando, FL.
[Poster]
Web of Science
** Dimai, HP; Paixao, T; Bertalan, Z; Ljuhar, R; Goetz, C; Ljuhar, D; Nehrer, S; Fahrleitner-Pammer, A
Artificial Intelligence (AI) Can Detect Bone Marrow Lesions (BMLs) on Plain Radiographs
J BONE MINER RES. 2019; 34: 199-199.-Annual Meeting of the American-Society-for-Bone-and Mineral Research; SEP 20-23, 2019; Orlando, FL.
[Poster]
Web of Science
** Dimai, HP; Paixao, T; Bertalan, Z; Ljuhar, R; Goetz, C; Ljuhar, D; Nehrer, S; Fahrleitner-Pammer, A; Kurth, A
DETECTING BONE MARROW LESIONS ON PLAIN RADIOGRAPHS USING ARTIFICIAL INTELLIGENCE (AI): DATA FROM THE OSTEOARTHRITIS INITIATIVE (OAI) STUDY
OSTEOPOROSIS INT. 2019; 30: S488-S488.-World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO); APR 04-07, 2019; Paris, FRANCE.
[Oral Communication]
Web of Science
** Geusens, P; Kendler, D; Fahrleitner-Pammer, A; Lopez-Romero, P; Marin, F
THE DISTRIBUTION OF PREVALENT AND INCIDENT VERTEBRAL FRACTURES IN THE TERIPARATIDE VERSUS RISEDRONATE "VERO" CLINICAL TRIAL
ANN RHEUM DIS. 2019; 78: 929-930.-Annual European Congress of Rheumatology (EULAR); JUN 12-15, 2019; Madrid, SPAIN.
Doi: 10.1136/annrheumdis-2019-eular.808
[Oral Communication]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Malle, O; Bergthaler, M; Muller, C; Krisper, P; Dimai, HP; Kirsch, A; Rosenkranz, A; Pieber, T; Obermayer-Pietsch, B; Fahrleitner-Pammer, A
USEFULNESS OF TRABECULAR BONE SCORE IN DIALYSIS PATIENTS
OSTEOPOROSIS INT. 2019; 30: S535-S536.-World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO); APR 04-07, 2019; Paris, FRANCE.
[Poster]
Web of Science
2018
Full paper/article (Journal)
** Dempster, DW; Brown, JP; Fahrleitner-Pammer, A; Kendler, D; Rizzo, S; Valter, I; Wagman, RB; Yin, X; Yue, SV; Boivin, G
Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis.
J Clin Endocrinol Metab. 2018; 103(7):2498-2509
Doi: 10.1210/jc.2017-02669
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Fahrleitner-Pammer, A; Bergthaler, M; Dimai, HP
Transplantation Bone Disease Osteopathy following Solid Organ Transplantation (SOT)
OSTEOLOGIE. 2018; 27(1): 24-28.
Doi: 10.1055/s-0038-1636975
Web of Science
FullText
FullText_MUG
** Feichtinger, X; Muschitz, C; Heimel, P; Baierl, A; Fahrleitner-Pammer, A; Redl, H; Resch, H; Geiger, E; Skalicky, S; Dormann, R; Plachel, F; Pietschmann, P; Grillari, J; Hackl, M; Kocijan, R
Bone-related Circulating MicroRNAs miR-29b-3p, miR-550a-3p, and miR-324-3p and their Association to Bone Microstructure and Histomorphometry.
SCI REP-UK. 2018; 8(1): 4867-4867.
Doi: 10.1038/s41598-018-22844-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Geusens, P; Marin, F; Kendler, DL; Russo, LA; Zerbini, CA; Minisola, S; Body, JJ; Lespessailles, E; Greenspan, SL; Bagur, A; Stepan, JJ; Lakatos, P; Casado, E; Moericke, R; López-Romero, P; Fahrleitner-Pammer, A
Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial.
J Bone Miner Res. 2018; 33(5):783-794
Doi: 10.1002/jbmr.3384
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kendler, DL; Marin, F; Zerbini, CAF; Russo, LA; Greenspan, SL; Zikan, V; Bagur, A; Malouf-Sierra, J; Lakatos, P; Fahrleitner-Pammer, A; Lespessailles, E; Minisola, S; Body, JJ; Geusens, P; Möricke, R; López-Romero, P
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
Lancet. 2018; 391(10117):230-240
Doi: 10.1016/S0140-6736(17)32137-2
Web of Science
PubMed
FullText
FullText_MUG
** Paschalis, EP; Krege, JH; Gamsjaeger, S; Eriksen, EF; Burr, DB; Disch, DP; Stepan, JJ; Fahrleitner-Pammer, A; Klaushofer, K; Marin, F; Pavo, I
Teriparatide Treatment Increases Mineral Content and Volume in Cortical and Trabecular Bone of Iliac Crest: A Comparison of Infrared Imaging With X-Ray-Based Bone Assessment Techniques.
J Bone Miner Res. 2018; 33(12):2230-2235
Doi: 10.1002/jbmr.3565
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Editorial
** Verheyen, N; Grübler, MR; Catena, C; Fahrleitner-Pammer, A; van Ballegooijen, AJ
The Bone-Cardiovascular Axis: Mechanisms and Clinical Relevance.
Int J Endocrinol. 2018; 2018(5):9689106-9689106
Doi: 10.1155/2018/9689106
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Bertalan, Z; Ljuhar, R; Nehrer, S; Ljuhar, D; Fahrleitner-Pammer, A; Dimai, HP
COMBINED FRACTAL- AND ENTROPY-BASED ANALYSIS OF BONE TEXTURE PREDICTS INCIDENT OSTEOARTHRITIS OF THE KNEE: DATA FROM THE MULTICENTER OSTEOARTHRITIS STUDY (MOST)
OSTEOPOROSIS INT. 2018; 29: S245-S245.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 19-22, 2018; Krakow, POLAND.
[Oral Communication]
Web of Science
** Bertalan, Z; Ljuhar, R; Norman, B; Ljuhar, D; Fahrleitner-Pammer, A; Dimai, HP; Nehrer, S
COMBINING FRACTAL- AND ENTROPY-BASED BONE TEXTURE ANALYSIS FOR THE PREDICTION OF OSTEOARTHRITIS: DATA FROM THE MULTICENTER OSTEOARTHRITIS STUDY (MOST)
OSTEOARTHR CARTILAGE. 2018; 26: S49-S49.-OARSI World Congress on Osteoarthritis - Promoting Clinical and Basic Research in Osteoarthritis; APR 26-29, 2018; Liverpool, ENGLAND.
Doi: 10.1016/j.joca.2018.02.112
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Body, JJ; Marin, F; Geusens, P; Zerbini, C; Fahrleitner-Pammer, A; Moericke, R; Casado, E; Stepan, J; Minisola, S; Lespessailles, E; Lopez-Romero, P; Kendler, D
Efficacy of Teriparatide Compared With Risedronate on FRAX (R)-defined Major Osteoporotic Fractures: A Post-hoc Analysis of the VERO Clinical Trial
J BONE MINER RES. 2018; 33: 113-113.-Annual Meeting of the American-Society-for-Bone-and-Mineral-Research; SEP 28-OCT 01, 2018; Montreal, CANADA.
[Oral Communication]
Web of Science
** Hadji, P; Marin, F; Kendler, D; Geusens, P; Russo, L; Malouf, J; Lakatos, P; Minisola, S; Lopez-Romero, P; Fahrleitner-Pammer, A
Patient Characteristics and Fracture Outcomes in Patients Previously Treated With Bisphosphonates or Treatment-naive in the Teriparatide versus Risedronate VERO Clinical Trial
J BONE MINER RES. 2018; 33: 286-286.-Annual Meeting of the American-Society-for-Bone-and-Mineral-Research; SEP 28-OCT 01, 2018; Montreal, CANADA.
[Poster]
Web of Science
** Ljuhar, R; Bertalan, Z; Nehrer, S; Norman, B; Dimai, HP; Fahrleitner-Pammer, A; Ljuhar, D
COMBINING FRACTAL- AND ENTROPY-BASED BONE TEXTURE ANALYSIS FOR THE PREDICTION OF OSTEOARTHRITIS: DATA FROM THE MULTICENTER OSTEOARTHRITIS STUDY (MOST)
ANN RHEUM DIS. 2018; 77: 787-787.-Congress of the European-League-Against-Rheumatism (EULAR); JUN 13-16, 2018; Amsterdam, NETHERLANDS.
Doi: 10.1136/annrheumdis-2018-eular.1118
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Malle, O; Bergthaler, M; Müller, C; Krisper, P; Dimai, HP; Kirsch, A; Rosenkranz, A; Pieber, T; Obermayer-Pietsch, O; Fahrleitner-Pammer, A
Usefulness of the Trabecular Bone Score in dialysis patients
J BONE MINER RES. 2018; 33: 101-101.-Annual Meeting of the American-Society-for-Bone-and-Mineral-Research; SEP 28-OCT 01, 2018; Montreal, CANADA.
[Poster]
Web of Science
** Malle, O; Borgstroem, F; Svedbom, A; Fahrleitner-Pammer, A; Dimai, SV; Dimai, HP
Treatment gap after fracture in osteoporosis patients: results of the austrian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS).
OSTEOPOROSIS INT. 2018; 29: S292-S292.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 19-22, 2018; Krakow, POLAND.
[Poster]
Web of Science
** Malle, O; Borgstroem, F; Svedbom, A; Fahrleitner-Pammer, A; Dimai, SV; Dimai, HP
Treatment gap after fracture in osteoporosis patients: results of the austrian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)
J BONE MINER RES. 2018; 33: 276-276.-Annual Meeting of the American-Society-for-Bone-and-Mineral-Research; SEP 28-OCT 01, 2018; Montreal, CANADA.
[Poster]
Web of Science
** Minisola, S; Marin, F; Kendler, D; Geusens, P; Zerbini, C; Russo, L; Greenspan, S; Casado, E; Fahrleitner-Pammer, A; Stepan, J; Lespessailles, E; Moericke, R; Bagur, A; Lakatos, P; Lopez-Romero, P; Body, JJ
VITAMIN D STATUS AND EFFECTS OF 25-HYDROXYVITAMIN D (25OHD) SERUM LEVELS ON THE RISK OF FRACTURES IN THE TERIPARATIDE VS. RISEDRONATE: VERO CLINICAL TRIAL
OSTEOPOROSIS INT. 2018; 29: S259-S260.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 19-22, 2018; Krakow, POLAND.
[Oral Communication]
Web of Science
** Ulm, S; Fahrleitner-Pammer, A; Pieber, T; Dobnig, H; Sourij, H; Amrein, K
Quality of Life and Health Competence in Patients with Diabetes mellitus and other endocrine Diseases
WIEN KLIN WOCHENSCHR. 2018; 130: 360-360.
[Poster]
Web of Science
2017
Full paper/article (Journal)
** Bone, HG; Wagman, RB; Brandi, ML; Brown, JP; Chapurlat, R; Cummings, SR; Czerwiński, E; Fahrleitner-Pammer, A; Kendler, DL; Lippuner, K; Reginster, JY; Roux, C; Malouf, J; Bradley, MN; Daizadeh, NS; Wang, A; Dakin, P; Pannacciulli, N; Dempster, DW; Papapoulos, S
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.
Lancet Diabetes Endocrinol. 2017; 5(7):513-523
Doi: 10.1016/S2213-8587(17)30138-9
Web of Science
PubMed
FullText
FullText_MUG
** Fahrleitner-Pammer, A; Papaioannou, N; Gielen, E; Feudjo Tepie, M; Toffis, C; Frieling, I; Geusens, P; Makras, P; Boschitsch, E; Callens, J; Anastasilakis, AD; Niedhart, C; Resch, H; Kalouche-Khalil, L; Hadji, P
Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium.
Arch Osteoporos. 2017; 12(1):58-58
Doi: 10.1007/s11657-017-0351-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Frauscher, B; Artinger, K; Kirsch, AH; Aringer, I; Moschovaki-Filippidou, F; Kétszeri, M; Schabhüttl, C; Rainer, PP; Schmidt, A; Stojakovic, T; Fahrleitner-Pammer, A; Rosenkranz, AR; Eller, P; Eller, K
A New Murine Model of Chronic Kidney Disease-Mineral and Bone Disorder.
Int J Endocrinol. 2017; 2017(3):1659071-1659071
Doi: 10.1155/2017/1659071
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Paschalis, EP; Gamsjaeger, S; Hassler, N; Fahrleitner-Pammer, A; Dobnig, H; Stepan, JJ; Pavo, I; Eriksen, EF; Klaushofer, K
Vitamin D and calcium supplementation for three years in postmenopausal osteoporosis significantly alters bone mineral and organic matrix quality.
Bone. 2017; 95(2):41-46
Doi: 10.1016/j.bone.2016.11.002
Web of Science
PubMed
FullText
FullText_MUG
** Schwetz, V; Schnedl, C; Urbanic-Purkart, T; Trummer, C; Dimai, HP; Fahrleitner-Pammer, A; Putz-Bankuti, C; Christopher, KB; Obermayer-Pietsch, B; Pieber, TR; Dobnig, H; Amrein, K
Effect of vitamin D3 on bone turnover markers in critical illness: post hoc analysis from the VITdAL-ICU study.
Osteoporos Int. 2017; 28(12):3347-3354
Doi: 10.1007/s00198-017-4190-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Fahrleitner-Pammer, A; Belyavskiy, E; Gruebler, MR; Dimai, HP; Amrein, K; Ablasser, K; Martensen, J; Catena, C; Pieske-Kraigher, E; Colantonio, C; Voelkl, J; Lang, F; Alesutan, I; Meinitzer, A; März, W; Brussee, H; Pieske, B; Pilz, S; Tomaschitz, A
Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial.
PLoS One. 2017; 12(4):e0173799-e0173799
Doi: 10.1371/journal.pone.0173799
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Grübler, MR; Meinitzer, A; Trummer, C; Schwetz, V; Amrein, K; Dimai, HP; März, W; Catena, C; von Lewinski, D; Voelkl, J; Alesutan, I; Fahrleitner-Pammer, A; Brussee, H; Pilz, S; Tomaschitz, A
Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism - The randomized, placebo-controlled EPATH trial.
Bone. 2017; 105(5):212-217
Doi: 10.1016/j.bone.2017.08.030
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Meinitzer, A; Grübler, MR; Ablasser, K; Kolesnik, E; Fahrleitner-Pammer, A; Belyavskiy, E; Trummer, C; Schwetz, V; Pieske-Kraigher, E; Voelkl, J; Alesutan, I; Catena, C; Sechi, LA; Brussee, H; Lewinski, DV; März, W; Pieske, B; Pilz, S; Tomaschitz, A
Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial.
Clin Chem Lab Med. 2017; 55(7):1034-1042
Doi: 10.1515/cclm-2016-1159
Web of Science
PubMed
FullText
FullText_MUG
** Wetzel, J; Pilz, S; Grübler, MR; Fahrleitner-Pammer, A; Dimai, HP; von Lewinski, D; Kolesnik, E; Perl, S; Trummer, C; Schwetz, V; Meinitzer, A; Belyavskiy, E; Völkl, J; Catena, C; Brandenburg, V; März, W; Pieske, B; Brussee, H; Tomaschitz, A; Verheyen, ND
Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial.
J Clin Hypertens (Greenwich). 2017; 19(11):1173-1180
Doi: 10.1111/jch.13064
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Case Report
** Fahrleitner-Pammer, A; Wagner, D; Krisper, P; Amrein, K; Dimai, H
Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report.
Osteoporos Int. 2017; 28(3):1149-1152
Doi: 10.1007/s00198-016-3858-2
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Bertalan, Z; Ljuhar, R; Nehrer, S; Ljuhar, D; Fahrleitner-Pammer, A; Dimai, HP
Combining fractal- and entropy-based bone texture analysis for the prediction of Osteoarthritis: data from the Multicenter Osteoarthritis study (MOST).
J BONE MINER RES. 2017; 32: S81-S82.
[Poster]
Web of Science
FullText
** Dempster, DW; Daizadeh, N; Fahrleitner-Pammer, A; Jensen, JEB; Kendler, D; Valter, I; Wagman, RB; Yue, S; Brown, JP
EFFECT OF 10 YEARS OF DENOSUMAB TREATMENT ON BONE HISTOLOGY AND HISTOMORPHOMETRY IN THE FREEDOM EXTENSION STUDY
OSTEOPOROSIS INT. .. 2017; 28: S63-S64.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; MAR 23-26, 2017; Florence, ITALY.
[Poster]
Web of Science
** Dimai, HP; Krisper, P; Wagner, D; Fahrleitner-Pammer, A
TERIPARATIDE TREATMENT IN A HEART TRANSPLANT PATIENT WITH CHRONIC KIDNEY DISEASE AND LOW-TURNOVER BONE DISEASE: A CASE REPORT
OSTEOPOROSIS INT. 2017; 28: S405-S406.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; MAR 23-26, 2017; Florence, ITALY.
[Poster]
Web of Science
** Dimai, HP; Ljuhar, R; Ljuhar, D; Norman, B; Haftner, T; Nehrer, S; Fahrleitner-Pammer, A
Fractal-based Assessment of Bone-antiresorptive Treatment Effects at the Lumbar Spine Using Conventional Radiographs; Results from a Pilot Study in a Sub-cohort of Postmenopausal Women who Participated in the FREEDOM Pivotal Trial and its Extension Phase
J BONE MINER RES. 2017; 32: S356-S356.
[Poster]
Web of Science
FullText
** Geusens, P; Marin, F; Kendler, DL; Russo, L; Zerbini, CAF; Greenspan, S; Minisola, S; Bagur, A; Lakatos, P; Casado, E; Fahrleitner-Pammer, A; Stepan, J; Lespessailles, E; Moericke, R; Body, JJ; Lopez-Romero, P
Teriparatide Compared with Risedronate and the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial.
J BONE MINER RES. 2017; 32: S22-S22.
[Oral Communication]
Web of Science
FullText
** Kendler, DL; Zerbini, C; Russo, L; Greenspan, S; Zikan, V; Bagur, A; Malouf, J; Lakatos, P; Fahrleitner-Pammer, A; Lespessailles, E; Minisola, S; Body, JJ; Geusens, P; Moericke, R; Lopez-Romero, P; Marin, F
EFFECTS OF 24 MONTHS TREATMENT OF TERIPARATIDE COMPARED WITH RISEDRONATE ON NEW FRACTURES IN POSTMENOPAUSAL WOMEN WITH SEVERE OSTEOPOROSIS: A RANDOMIZED, DOUBLE-DUMMY, CLINICAL TRIAL
OSTEOPOROSIS INT. .. 2017; 28: S69-S70.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; MAR 23-26, 2017; Florence, ITALY.
[Poster]
Web of Science
** Ljuhar, R; Dimai, HP; Ljuhar, D; Hladuvka, J; Mai, MBT; Canhao, H; Branco, J; Rodrigues, AM; Gouveia, N; Fahrleitner-Pammer, A; Nehrer, S
A NOVEL COMBINATION OF BONE MICRO-ARCHITECTURE DESCRIPTORS FOR THE IDENTIFICATION OF OSTEOARTHRITIS
RHEUMATOLOGY. 2017; 56: 163-163.-Rheumatology Conference; APR 25-27, 2017; Birmingham, ENGLAND.
[Oral Communication]
Web of Science
** Ljuhar, R; Haftner, T; Bertalan, Z; Ljuhar, D; Fahrleitner-Pammer, A; Dimai, HP; Nehrer, S
A NOVEL METHOD FOR IDENTIFYING RADIOGRAPHIC BASELINE RISK OF OSTEOARTHRITIS USING AN ANISOTROPY-BASED TEXTURE ANALYSIS ALGORITHM: DATA FROM THE OSTEOARTHRITIS INITIATIVE
ANN RHEUM DIS. 2017; 76: 1423-1423.-Annual European Congress of Rheumatology; JUN 14-17, 2017; Madrid, SPAIN.
Doi: 10.1136/annrheumdis-2017-eular.5860
[Poster]
Web of Science
FullText
FullText_MUG
** Ljuhar, R; Haftner, T; Ljuhar, D; Norman, B; Fahrleitner-Pammer, A; Dimai, HP; Hladuvka, J; Nehrer, S
A NOVEL METHOD FOR IDENTIFYING RADIOGRAPHIC BASELINE RISK OF OSTEOARTHRITIS USING AN ANISOTROPY-BASED TEXTURE ANALYSIS ALGORITHM: DATA FROM THE OSTEOARTHRITIS INITIATIVE
OSTEOARTHR CARTILAGE. .. 2017; 25: S263-S263.-World Congress of the Osteoarthritis-Research-Society-International (OARSI) on Osteoarthritis; APR 27-30, 2017; Las Vegas, NV.
Doi: 10.1016/j.joca.2017.02.443
[Poster]
Web of Science
FullText
FullText_MUG
** Paschalis, E; Krege, J; Gamsjaeger, S; Eriksen, E; Burr, D; Disch, D; Stepan, J; Fahrleitner-Pammer, A; Klaushofer, K; Pavo, I
DEXA areal BMD Measurement Underestimates the Bone Forming Effects of Teriparatide.
J BONE MINER RES. 2017; 32: S272-S272.
[Poster]
Web of Science
FullText
** Zerbini, CAF; Geusens, P; Lespessailles, E; Body, JJ; Casado, E; Stepan, J; Kendler, DL; Russo, L; Greenspan, SL; Minisola, S; Bagur, A; Lakatos, P; Fahrleitner-Pammer, A; Moricke, R; Lopez-Romero, P; Marin, F
Teriparatide Compared with Risedronate and the Risk of Clinical Vertebral Fractures: 2-Year Results of a Randomized, Double-Dummy Clinical Trial
ARTHRITIS RHEUMATOL. .. 2017; 69:
[Poster]
Web of Science
2016
Full paper/article (Journal)
** Amrein, K; Dimai, HP; Dobnig, H; Fahrleitner-Pammer, A
Plasmapheresis and Osteoporosis: The Absence of Evidence Is Not the Evidence of Absence
J MINERAL. 2016; 23(2): 44-47.
[OPEN ACCESS]
Web of Science
** Fahrleitner-Pammer, A; Burr, D; Dobnig, H; Stepan, JJ; Petto, H; Li, J; Krege, JH; Pavo, I
Improvement of cancellous bone microstructure in patients on teriparatide following alendronate pretreatment.
Bone. 2016; 89(6):16-24
Doi: 10.1016/j.bone.2016.05.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Grübler, MR; Gaksch, M; Kienreich, K; Verheyen, N; Schmid, J; Ó, Hartaigh, B; Richtig, G; Scharnagl, H; Meinitzer, A; Fahrleitner-Pammer, A; März, W; Tomaschitz, A; Pilz, S
Effects of vitamin D supplementation on glycated haemoglobin and fasting glucose levels in hypertensive patients: a randomized controlled trial.
Diabetes Obes Metab. 2016; 18(10):1006-12
Doi: 10.1111/dom.12709
Web of Science
PubMed
FullText
FullText_MUG
** Grübler, MR; Gaksch, M; Kienreich, K; Verheyen, N; Schmid, J; Ó, Hartaigh, BW; Richtig, G; Scharnagl, H; Meinitzer, A; Pieske, B; Fahrleitner-Pammer, A; März, W; Tomaschitz, A; Pilz, S
Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial.
J Clin Hypertens (Greenwich). 2016; 18(7):608-13
Doi: 10.1111/jch.12825
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Grübler, MR; Kienreich, K; Gaksch, M; Verheyen, N; Hartaigh, BÓ; Fahrleitner-Pammer, A; März, W; Schmid, J; Oberreither, EM; Wetzel, J; Catena, C; Sechi, LA; Pieske, B; Tomaschitz, A; Pilz, S
Aldosterone-to-Renin Ratio Is Associated With Reduced 24-Hour Heart Rate Variability and QTc Prolongation in Hypertensive Patients.
Medicine (Baltimore). 2016; 95(8):e2794
Doi: 10.1097/MD.0000000000002794
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kocijan, R; Muschitz, C; Geiger, E; Skalicky, S; Baierl, A; Dormann, R; Plachel, F; Feichtinger, X; Heimel, P; Fahrleitner-Pammer, A; Grillari, J; Redl, H; Resch, H; Hackl, M
Circulating microRNA Signatures in Patients With Idiopathic and Postmenopausal Osteoporosis and Fragility Fractures.
J Clin Endocrinol Metab. 2016; 101(11):4125-4134
Doi: 10.1210/jc.2016-2365
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tomaschitz, A; Rus-Machan, J; Dimai, HP; Seiwald, G; Brussee, H; Weinrauch, V; Verheyen, N; Fahrleitner-Pammer, A; Pilz, S
The Bone-Cardiovascular Axis: A Systematic Review of Prospective Studies
J MINERAL. 2016; 23(3): 86-93.
[OPEN ACCESS]
Web of Science
** Tomaschitz, A; Verheyen, N; Meinitzer, A; Pieske, B; Belyavskiy, E; Brussee, H; Haas, J; März, W; Pieske-Kraigher, E; Verheyen, S; Ofner-Ziegenfuss, L; Hartaigh, BÓ; Schwetz, V; Aberer, F; Grübler, M; Lang, F; Alesutan, I; Voelkl, J; Gaksch, M; Horina, JH; Dimai, HP; Rus-Machan, J; Stiegler, C; Ritz, E; Fahrleitner-Pammer, A; Pilz, S
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.
J Hypertens. 2016; 34(7):1347-56
Doi: 10.1097/HJH.0000000000000927
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Fahrleitner-Pammer, A; Pieske, B; Meinitzer, A; Belyavskiy, E; Wetzel, J; Gaksch, M; Grübler, MR; Catena, C; Sechi, LA; Van, Ballegooijen, AJ; Brandenburg, VM; Scharnagl, H; Perl, S; Brussee, H; März, W; Pilz, S; Tomaschitz, A
Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
J Hypertens. 2016; 34(9):1778-86
Doi: 10.1097/HJH.0000000000001004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, ND; Kienreich, K; Gaksch, M; van, Ballegooijen, AJ; Grübler, MR; Hartaigh, BÓ; Schmid, J; Fahrleitner-Pammer, A; Kraigher-Krainer, E; Colantonio, C; Belyavskiy, E; Treiber, G; Catena, C; Brussee, H; Pieske, B; März, W; Tomaschitz, A; Pilz, S
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study.
J Clin Hypertens (Greenwich). 2016; 18(6):543-50
Doi: 10.1111/jch.12710
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wibmer, C; Amrein, K; Fahrleitner-Pammer, A; Gilg, MM; Berghold, A; Hutterer, GC; Maurer-Ertl, W; Gerger, A; Leithner, A; Pichler, M; Szkandera, J
Serum sclerostin levels in renal cell carcinoma patients with bone metastases.
Sci Rep. 2016; 6(4):33551-33551
Doi: 10.1038/srep33551
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Bone, H; Brandi, ML; Brown, J; Chapurlat, R; Cummings, S; Czerwinski, E; Fahrleitner-Pamer, A; Kendler, D; Lippinur, K; Reginster, JY; Vittinghoff, E; Daizadeh, N; Wang, A; Dakin, P; Wagman, R; Papapoulos, S
Ten Years of Denosumab Treatment in Postmenopausal Women With Osteoporosis: Results from the FREEDOM Extension Trial
J RHEUMATOL. 2016; 43(6):1209-1209.-Canadian-Rheumatology-Association Meeting; FEB 17-20, 2016; Alberta, CANADA.
[Oral Communication]
Web of Science
** Bone, HG; Brandi, ML; Brown, JP; Chapurlat, R; Cummings, SR; Czerwinski, E; Fahrleitner-Pammer, A; Kendler, DL; Lippuner, K; Reginster, JY; Vittinghoff, E; Daizadeh, NS; Wang, A; Dakin, P; Wagman, RB; Papapoulos, SE
TEN YEARS OF DENOSUMAB (DMAB) TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FREEDOM EXTENSION TRIAL
OSTEOPOROSIS INT. 2016; 27: S135-S136.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 14-17, 2016; Malaga, SPAIN.
[Oral Communication]
Web of Science
** Ljuhar, R; Norman, B; Ljuhar, D; Haftner, T; Hladuvka, J; Canhao, H; Branco, J; Rodrigues, A; Gouveia, N; Nehrer, S; Fahrleitner-Pammer, A; Dimai, HP
A NOVEL METHOD FOR THE ASSESSMENT OF KNEE JOINT SPACE WIDTH AND SUBCHONDRAL BONE MICRO ARCHITECTURE
OSTEOARTHR CARTILAGE. 2016; 24: S379-S379.
Doi: 10.1016/j.joca.2016.01.677
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Ljuhar, R; Norman, B; Ljuhar, D; Haftner, T; Hladuvka, J; Mai, PBT; Canhao, H; Branco, J; Rodrigues, AM; Gouveia, N; Nehrer, S; Fahrleitner-Pammer, A; Dimai, HP
A CLINICAL STUDY TO EXAMINE THRESHOLDS OF JOINT SPACE WIDTH AND JOINT SPACE AREA FOR IDENTIFICATION OF KNEE OSTEOARTHRITIS
OSTEOPOROSIS INT. 2016; 27: S488-S489.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 14-17, 2016; Malaga, SPAIN.
[Oral Communication]
Web of Science
** Ljuhar, R; Norman, B; Ljuhar, D; Haftner, T; Hladuvka, J; Mai, PBT; Canhao, H; Branco, J; Rodrigues, AM; Gouveia, N; Nehrer, S; Fahrleitner-Pammer, A; Dimai, HP
A NOVEL FEATURE SELECTION ALGORITHM BASED ON BONE MICROARCHITECTURE ANALYSIS TO IDENTIFY OSTEOARTHRITIS
OSTEOPOROSIS INT. 2016; 27: S426-S427.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 14-17, 2016; Malaga, SPAIN.
[Oral Communication]
Web of Science
** Muschitz, CM; Kocijan, R; Haschka, J; Pahr, DP; Kaider, AK; Hans, DH; Fahrleitner-Pammer, A; Resch, HR
TBS REFLECTS TRABECULAR MICROARCHITECTURE IN PREMENOPAUSAL WOMEN AND SIMILARLY AGED MEN WITH LOW TRAUMATIC FRACTURES
OSTEOPOROSIS INT. .. 2016; 27: S80-S81.-WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 14-17, 2016; Malaga, SPAIN.
[Poster]
Web of Science
** Verheyen, N; Grubler, M; Fahrleitner-Pammer, A; Pilz, S; Tomaschitz, A; Marz, W
Plasma parathyroid hormone is independently associated with atrial fibrillation - Insights from the LURIC study
WIEN KLIN WOCHENSCHR. 2016; 128: S307-S308.
[Poster]
Web of Science
** Verheyen, N; Meinitzer, A; Ablasser, K; Fahrleitner-Pammer, A; Brussee, H; Pilz, S; Tomaschitz, A
Serum kynurenine, quinolinic acid and cardiac stiffness parameters: the eplerenone in primary hyperparathyroidism study
WIEN KLIN WOCHENSCHR. 2016; 128: S308-S308.
[Poster]
Web of Science
** Wetzel, J; Pilz, S; Gruebler, M; Fahrleitner-Pammer, A; Dimai, HP; Von Lewinski, D; Kolesnik, E; Perl, S; Weinrauch, V; Maerz, W; Belyavskiy, E; Pieske, B; Brussee, H; Tomaschitz, A; Verheyen, N
Parathyroid hormone is independently associated with systolic blood pressure, pulse wave velocity and left ventricular mass index in patients with primary hyperparathyroidism
EUR HEART J. 2016; 37: 417-417.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY.
[Poster]
Web of Science
2015
Full paper/article (Journal)
** Hadji, P; Papaioannou, N; Gielen, E; Feudjo Tepie, M; Zhang, E; Frieling, I; Geusens, P; Makras, P; Resch, H; Möller, G; Kalouche-Khalil, L; Fahrleitner-Pammer, A
Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
Osteoporos Int. 2015; 26(10):2479-2489
Doi: 10.1007/s00198-015-3164-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Muschitz, C; Kocijan, R; Haschka, J; Pahr, D; Kaider, A; Pietschmann, P; Hans, D; Muschitz, GK; Fahrleitner-Pammer, A; Resch, H
TBS reflects trabecular microarchitecture in premenopausal women and men with idiopathic osteoporosis and low-traumatic fractures.
Bone. 2015; 79(1):259-266
Doi: 10.1016/j.bone.2015.06.007
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Gaksch, M; Kienreich, K; Grübler, M; Verheyen, N; Fahrleitner-Pammer, A; Treiber, G; Drechsler, C; Ó, Hartaigh, B; Obermayer-Pietsch, B; Schwetz, V; Aberer, F; Mader, J; Scharnagl, H; Meinitzer, A; Lerchbaum, E; Dekker, JM; Zittermann, A; März, W; Tomaschitz, A
Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial.
Hypertension. 2015; 65(6):1195-201
Doi: 10.1161/HYPERTENSIONAHA.115.05319
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tomaschitz, A; Piecha, G; Ritz, E; Meinitzer, A; Haas, J; Pieske, B; Wiecek, A; Rus-Machan, J; Toplak, H; März, W; Verheyen, N; Gaksch, M; Amrein, K; Kraigher-Krainer, E; Fahrleitner-Pammer, A; Pilz, S
Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications.
Clin Exp Hypertens. 2015; 37(2):108-15
Doi: 10.3109/10641963.2014.913604
Web of Science
PubMed
FullText
FullText_MUG
** Tomaschitz, A; Pilz, S; Rus-Machan, J; Meinitzer, A; Brandenburg, VM; Scharnagl, H; Kapl, M; Grammer, T; Ritz, E; Horina, JH; Kleber, ME; Pieske, B; Kraigher-Krainer, E; Hartaigh, BÓ; Toplak, H; van Ballegooijen, AJ; Amrein, K; Fahrleitner-Pammer, A; März, W
Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk.
Int J Cardiol. 2015; 184(9):710-716
Doi: 10.1016/j.ijcard.2015.03.062
Web of Science
PubMed
FullText
FullText_MUG
** Tomaschitz, A; Verheyen, N; Gaksch, M; Meinitzer, A; Pieske, B; Kraigher-Krainer, E; Colantonio, C; März, W; Schmidt, A; Belyavskiy, E; Rus-Machan, J; van, Ballegooijen, AJ; Stiegler, C; Amrein, K; Ritz, E; Fahrleitner-Pammer, A; Pilz, S
Homoarginine in patients with primary hyperparathyroidism.
Am J Med Sci. 2015; 349(4):306-11
Doi: 10.1097/MAJ.0000000000000419
Web of Science
PubMed
FullText
FullText_MUG
Review
** Schnedl, C; Fahrleitner-Pammer, A; Pietschmann, P; Amrein, K
FGF23 in Acute and Chronic Illness.
Dis Markers. 2015; 2015(12):358086-358086
Doi: 10.1155/2015/358086
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Bilezkian, JP; Benhamou, CL; Lin, CJF; Brown, JP; Fahrleitner-Pammer, A; Franek, E; Gilchrist, N; Simon, JA; Valter, I; Peters, K
Denosumab restores cortical bone loss at the distal radius associated with aging and reduces wrist fracture risk: analyses from the FREEDOM extension cross-over group
AUSTRALAS J AGEING. . 2015; 34: 65-65.
[Oral Communication]
Web of Science
** Verheyen, N; Wetzel, J; Martensen, J; Belyavskiy, E; Schmidt, A; Colantonio, C; Catena, C; Gaksch, M; Grübler, MR; Kraigher-Krainer, E; Pieske, B; Meinitzer, A; Rus-Machan, J; Fahrleitner-Pammer, A; Pilz, S; Tomaschitz, A
9B.05: ASSOCIATION OF PLASMA PARATHYROID HORMONE WITH NIGHTTIME BLOOD PRESSURE IN PRIMARY HYPERPARATHYROIDISM-THE "EPLERENONE IN PRIMARY HYPERPARATHYROIDISM" TRIAL.
J Hypertens. . 2015; 33 Suppl 1(10):e121-e121.
Doi: 10.1097/01.hjh.0000467677.24307.ad
[Oral Communication]
Web of Science
PubMed
FullText
FullText_MUG
Comment
** Amrein, K; Fahrleitner-Pammer, A; Dimai, HP
Bone - a casualty of ICU survival?
Crit Care. 2015; 19(6):253-253
Doi: 10.1186/s13054-015-0977-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Full paper/article (Journal)
** Amrein, K; Dobnig, H; Wagner, D; Piswanger-Sölkner, C; Pieber, TR; Pilz, S; Tomaschitz, A; Dimai, HP; Fahrleitner-Pammer, A
Sclerostin in institutionalized elderly women: associations with quantitative bone ultrasound, bone turnover, fractures, and mortality.
J Am Geriatr Soc. 2014; 62(6):1023-1029
Doi: 10.1111/jgs.12791
Web of Science
PubMed
FullText
FullText_MUG
** Dimai, HP; Svedbom, A; Fahrleitner-Pammer, A; Resch, H; Muschitz, C; Thaler, H; Szivak, M; Amrein, K; Borgström, F
Epidemiology of distal forearm fractures in Austria between 1989 and 2010.
Osteoporos Int. 2014; 25(9):2297-2306
Doi: 10.1007/s00198-014-2766-6
Web of Science
PubMed
FullText
FullText_MUG
** Grübler, MR; Kienreich, K; Gaksch, M; Verheyen, N; Fahrleitner-Pammer, A; Schmid, J; Grogorenz, J; Ablasser, K; Pieske, B; Tomaschitz, A; Pilz, S
Aldosterone to active renin ratio is associated with nocturnal blood pressure in obese and treated hypertensive patients: the Styrian Hypertension Study.
J Clin Hypertens (Greenwich). 2014; 16(4):289-94
Doi: 10.1111/jch.12274
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kerschan-Schindl, K; Mikosch, P; Obermayer-Pietsch, B; Gasser, RW; Dimai, HP; Fahrleitner-Pammer, A; Dobnig, H; Roschger, P; Preisinger, E; Klaushofer, K; Resch, H; Pietschmann, P
Current controversies in clinical management of postmenopausal osteoporosis.
Exp Clin Endocrinol Diabetes. 2014; 122(8):437-444
Doi: 10.1055/s-0034-1374610
Web of Science
PubMed
FullText
FullText_MUG
** Kocijan, R; Muschitz, C; Fahrleitner-Pammer, A; Amrein, K; Pietschmann, P; Haschka, J; Dinu, S; Kapiotis, S; Resch, H
Serum sclerostin levels are decreased in adult patients with different types of osteogenesis imperfecta.
J Clin Endocrinol Metab. 2014; 99(2):E311-E319
Doi: 10.1210/jc.2013-2244
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ma, YL; Zeng, QQ; Chiang, AY; Burr, D; Li, J; Dobnig, H; Fahrleitner-Pammer, A; Michalská, D; Marin, F; Pavo, I; Stepan, JJ
Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment.
Bone. 2014; 59(5):139-147
Doi: 10.1016/j.bone.2013.11.011
Web of Science
PubMed
FullText
FullText_MUG
** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Pavo, I; Haschka, J; Schima, W; Kapiotis, S; Resch, H
Overlapping and continued alendronate or raloxifene administration in patients on teriparatide: effects on areal and volumetric bone mineral density--the CONFORS Study.
J Bone Miner Res. 2014; 29(8):1777-1785
Doi: 10.1002/jbmr.2216
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Roux, C; Hofbauer, LC; Ho, PR; Wark, JD; Zillikens, MC; Fahrleitner-Pammer, A; Hawkins, F; Micaelo, M; Minisola, S; Papaioannou, N; Stone, M; Ferreira, I; Siddhanti, S; Wagman, RB; Brown, JP
Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study.
Bone. 2014; 58(2):48-54
Doi: 10.1016/j.bone.2013.10.006
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tomaschitz, A; Meinitzer, A; Pilz, S; Rus-Machan, J; Genser, B; Drechsler, C; Grammer, T; Krane, V; Ritz, E; Kleber, ME; Pieske, B; Kraigher-Krainer, E; Fahrleitner-Pammer, A; Wanner, C; Boehm, BO; März, W
Homoarginine, kidney function and cardiovascular mortality risk.
Nephrol Dial Transplant. 2014; 29(3):663-671
Doi: 10.1093/ndt/gft512
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Tomaschitz, A; Ritz, E; Pieske, B; Rus-Machan, J; Kienreich, K; Verheyen, N; Gaksch, M; Grübler, M; Fahrleitner-Pammer, A; Mrak, P; Toplak, H; Kraigher-Krainer, E; März, W; Pilz, S
Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
Metabolism. 2014; 63(1):20-31
Doi: 10.1016/j.metabol.2013.08.016
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Bilezikian, JP; Benhamou, CL; Lin, CJF; Brown, JP; Daizadeh, NS; Ebeling, PR; Fahrleitner-Pammer, A; Franek, E; Gilchrist, N; Miller, PD; Simon, JA; Valter, I; Zerbini, CAF; Libanati, C
Denosumab Restores Cortical Bone Loss at the Distal Radius Associated with Aging and Reduces Wrist Fracture Risk. Analyses from the Cross-over Group in the Extension of Denosumab Pivotal Fracture Trial
ARTHRITIS RHEUMATOL. . 2014; 66: S788-S789.
[Poster]
Web of Science
** Hadji, P; Papaioannou, NA; Gielen, E; Tepie, MF; Zhang, E; Kalouche-Khalil, L; Fahrleitner-Pammer, A
12-MONTH PERSISTENCE WITH DENOSUMAB (DMAB) IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO): INTERIM RESULTS OF A 24-MONTH PROSPECTIVE OBSERVATIONAL STUDY IN GERMANY, AUSTRIA, GREECE AND BELGIUM
OSTEOPOROSIS INT. 2014; 25: S181-S182.-World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; APR 02-05, 2014; Seville, SPAIN.
[Oral Communication]
Web of Science
2013
Full paper/article (Journal)
** Dimai, HP; Svedbom, A; Fahrleitner-Pammer, A; Pieber, T; Resch, H; Zwettler, E; Thaler, H; Szivak, M; Amrein, K; Borgström, F
Epidemiology of proximal humeral fractures in Austria between 1989 and 2008.
Osteoporos Int. 2013; 24(9):2413-2421
Doi: 10.1007/s00198-013-2339-0
Web of Science
PubMed
FullText
FullText_MUG
** Friedl, C; Hemetsberger, M; Mader, J; Fahrleitner-Pammer, A; Pieber, TR; Rosenkranz, AR
Awareness of chronic kidney disease in Austria: a frequently under-recognized clinical picture.
Wien Klin Wochenschr. 2013; 125(13-14):362-367
Doi: 10.1007/s00508-013-0374-7
Web of Science
PubMed
FullText
FullText_MUG
** Kleber, ME; Seppälä, I; Pilz, S; Hoffmann, MM; Tomaschitz, A; Oksala, N; Raitoharju, E; Lyytikäinen, LP; Mäkelä, KM; Laaksonen, R; Kähönen, M; Raitakari, OT; Huang, J; Kienreich, K; Fahrleitner-Pammer, A; Drechsler, C; Krane, V; Boehm, BO; Koenig, W; Wanner, C; Lehtimäki, T; März, W; Meinitzer, A
Genome-wide association study identifies 3 genomic loci significantly associated with serum levels of homoarginine: the AtheroRemo Consortium.
Circ Cardiovasc Genet. 2013; 6(5):505-513
Doi: 10.1161/CIRCGENETICS.113.000108
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ljunggren, Ö; Barrett, A; Stoykov, I; Langdahl, BL; Lems, WF; Walsh, JB; Fahrleitner-Pammer, A; Rajzbaum, G; Jakob, F; Karras, D; Marin, F
Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study.
BMC Musculoskelet Disord. 2013; 14(8):251-251
Doi: 10.1186/1471-2474-14-251
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Lung, S; Resch, H
Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral density.
J Bone Miner Res. 2013; 28(1):196-205
Doi: 10.1002/jbmr.1716
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Meinitzer, A; Tomaschitz, A; Kienreich, K; Dobnig, H; Schwarz, M; Wagner, D; Drechsler, C; Piswanger-Sölkner, C; März, W; Fahrleitner-Pammer, A
Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients.
Osteoporos Int. 2013; 24(1):377-381
Doi: 10.1007/s00198-012-1950-9
Web of Science
PubMed
FullText
FullText_MUG
** Tomaschitz, A; Pilz, S; Pieske, B; Ritz, E; März, W; Meinitzer, A; Dobnig, H; Amrein, K; Kienreich, K; Verheyen, N; Kraigher-Krainer, E; Drechsler, C; Colantonio, C; Wagner, D; Fahrleitner-Pammer, A
Circulating aldosterone and mortality in female nursing home residents.
Exp Gerontol. 2013; 48(3):313-318
Doi: 10.1016/j.exger.2013.01.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wagner, D; Bradatsch, A; Kniepeiss, D; Schaffellner, S; Jakoby, E; Muller, H; Pirker, S; Fahrleitner-Pammer, A; Tscheliessnigg, KH; Iberer, F;
Incidence of ischemic type biliary lesions after liver transplantation using piggyback technique and retrograde reperfusion.
EUR SURG. 2013; 45(1): 3-7.
Doi: 10.1007/s10353-012-0166-8
Web of Science
FullText
FullText_MUG
** Werkgartner, G; Wagner, D; Manhal, S; Fahrleitner-Pammer, A; Mischinger, HJ; Wagner, M; Grgic, R; Roller, RE; Kniepeiss, D
Long-term quality of life of liver transplant recipients beyond 60 years of age.
Age (Dordr). 2013; 35(6):2485-2492
Doi: 10.1007/s11357-013-9527-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Kerschan-Schindl, K; Haschka, J; Obermayer-Pietsch, B; Gasser, RW; Dimai, HP; Fahrleitner-Pammer, A; Dobnig, H; Roschger, P; Preisinger, E; Klaushofer, K; Resch, H; Pietschmann, P
How long should women with postmenopausal osteoporosis be treated with a bisphosphonate?
Horm Metab Res. 2013; 45(9):621-628
Doi: 10.1055/s-0033-1345207
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Pilz, S; Eller, K; Kienreich, K; Fahrleitner-Pammer, A; Pieske, B; Ritz, E; Tomaschitz, A
Cinacalcet hydrochloride for the treatment of hyperparathyroidism.
Expert Opin Pharmacother. 2013; 14(6):793-806
Doi: 10.1517/14656566.2013.777041
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Grubler, M; Kienreich, K; Tomaschitz, A; Verheyen, N; Gaksch, M; Fahrleitner-Pammer, A; Schmid, J; Pieske, B; Pieber, TR; Pilz, S;
Aldosterone to renin ratio is associated with 24 hour ambulatory blood pressure in essential hypertensives: the Styrian Hypertension study.
EUR HEART J. 2013; 34: 1051-1051.-Congress of the European-Society-of-Cardiology (ESC); AUG 31-SEP 04, 2013; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
** Grubler, MR; Verheyen, N; Pilz, S; Kienreich, K; Gaksch, M; Schmid, J; Rus-Machan, J; Fahrleitner-Pammer, A; Kraigher-Krainer, E; Pieske, B; Marz, W; Tomaschitz, A
Is Resting Heart Rate Really Associated With Cardiovascular Mortality?
CIRCULATION. 2013; 128(22):
[Poster]
Web of Science
FullText
** Grubler, MR; Verheyen, N; Tomaschitz, A; Kienreich, K; Gaksch, M; Bersuch, LA; Fahrleitner-Pammer, A; Schmid, J; Marz, W; Pieske, B; Pilz, S
Nocturnal Diastolic Blood Pressure is Associated With 24 Hour Urinary Albumin in Essential Hypertensive Patients
CIRCULATION. 2013; 128(22):
[Oral Communication]
Web of Science
FullText
** Hofbauer, LC; Fahrleitner-Pammer, A; Ho, PR; Hawkins, F; Roux, C; Micaelo, M; Minisola, S; Papaioannou, NA; Stone, M; Wark, J; Zillikens, MC; Ferreira, I; Siddhanti, S; Wagman, RB; Brown, JP;
EFFICACY AND SAFETY OF DENOSUMAB VS. RISEDRONATE IN POSTMENOPAUSAL WOMEN SUBOPTIMALLY ADHERENT TO ALENDRONATE: RESULTS FROM A RANDOMIZED OPEN-LABEL STUDY.
OSTEOPOROSIS INT. 2013; 24: S218-S219.-European Congress on Osteoporosis and Osteoarthritis (ESCEO-IOF); APR 17-20, 2013; Rome, ITALY.
[Oral Communication]
Web of Science
** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Lung, S; Resch, H;
OVERLAPPING AND FOLLOW-U P OF ALENDRONATE TO TERIPARATIDE TREATMENT RESULTS IN MAINTENANCE OF EXCESS BMD GAIN.
OSTEOPOROSIS INT. 2013; 24: S93-S93.-European Congress on Osteoporosis and Osteoarthritis (ESCEO-IOF); APR 17-20, 2013; Rome, ITALY.
[Oral Communication]
Web of Science
** Roux, C; Fahrleitner-Pammer, A; Ho, PR; Hawkins, F; Hofbauer, LC; Micaelo, M; Minisola, S; Papaioannou, N; Stone, M; Wark, J; Zillikens, MC; Ferreira, I; Siddhanti, S; Wagman, RB; Brown, JP
DENOSUMAB VERSUS RISEDRONATE: EFFICACY AND SAFETY IN POSTMENOPAUSAL WOMEN SUBOPTIMALLY ADHERENT TO ALENDRONATE THERAPY IN A RANDOMIZED OPEN-LABEL STUDY
ANN RHEUM DIS. 2013; 72: 306-306.-ASBMR; Oct 2013; Minneapolis.
[Oral Communication]
Web of Science
** Verheyen, N; Grubler, M; Pilz, S; Kienreich, K; Gaksch, M; Schmid, J; Bersuch, LA; Pieske, B; Kraigher-Krainer, E; Fahrleitner-Pammer, A; Boehm, BO; Marz, W; Tomaschitz, A
Serum Parathyroid Hormone is Independently Associated With Atrial Fibrillation: Insights From the LURIC Study
CIRCULATION. 2013; 128(22):
[Poster]
Web of Science
FullText
** Werkgartner, G; Fahrleitner-Pammer, A; Roller-Wirnsberger, R; Kniepeiss, D; Wagner, D
LONG TERM QUALITY OF LIFE OF LIVER TRANSPLANT RECIPIENTS BEYOND SIXTY YEARS OF AGE
TRANSPL INT. . 2013; 26: 189-189.
[Poster]
Web of Science
2012
Full paper/article (Journal)
** Amrein, K; Amrein, S; Drexler, C; Dimai, HP; Dobnig, H; Pfeifer, K; Tomaschitz, A; Pieber, TR; Fahrleitner-Pammer, A
Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.
J Clin Endocrinol Metab. 2012; 97(1):148-154
Doi: 10.1210/jc.2011-2152
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Friedl, C; Sampl, E; Prandl, EC; Wagner, D; Piswanger-Soelkner, JC; Rosenkranz, AR; Fahrleitner-Pammer, A
Osteoporosis, weight gain and atypical fat accumulations - a typical feature not only for Cushing's, but also Madelung's disease: A case report.
Wien Klin Wochenschr. 2012; 124(5-6):188-192
Doi: 10.1007/s00508-011-0045-5
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Jakob, F; Oertel, H; Langdahl, B; Ljunggren, O; Barrett, A; Karras, D; Walsh, JB; Fahrleitner-Pammer, A; Rajzbaum, G; Barker, C; Lems, WF; Marin, F
Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study.
Eur J Endocrinol. 2012; 166(1):87-97
Doi: 10.1530/EJE-11-0740
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Karras, D; Stoykov, I; Lems, WF; Langdahl, BL; Ljunggren, ; Barrett, A; Walsh, JB; Fahrleitner-Pammer, A; Rajzbaum, G; Jakob, F; Marin, F
Effectiveness of teriparatide in postmenopausal women with osteoporosis and glucocorticoid use: 3-year results from the EFOS study.
J Rheumatol. 2012; 39(3):600-609
Doi: 10.3899/jrheum.110947
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Dobnig, H; Tomaschitz, A; Kienreich, K; Meinitzer, A; Friedl, C; Wagner, D; Piswanger-Sölkner, C; März, W; Fahrleitner-Pammer, A
Low 25-hydroxyvitamin D is associated with increased mortality in female nursing home residents.
J Clin Endocrinol Metab. 2012; 97(4): E653-E657.
Doi: 10.1210/jc.2011-3043
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Kienreich, K; Drechsler, C; Ritz, E; Fahrleitner-Pammer, A; Gaksch, M; Meinitzer, A; März, W; Pieber, TR; Tomaschitz, A
Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.
J Clin Endocrinol Metab. 2012; 97(1):E75-9
Doi: 10.1210/jc.2011-2183
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tomaschitz, A; Fahrleitner-Pammer, A; Pieske, B; Verheyen, N; Amrein, K; Ritz, E; Kienreich, K; Horina, JH; Schmidt, A; Kraigher-Krainer, E; Colantonio, C; Meinitzer, A; Pilz, S
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial.
BMC Endocr Disord. 2012; 12(12):19-19
Doi: 10.1186/1472-6823-12-19
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tomaschitz, A; Ritz, E; Pieske, B; Fahrleitner-Pammer, A; Kienreich, K; Horina, JH; Drechsler, C; März, W; Ofner, M; Pieber, TR; Pilz, S
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
Cardiovasc Res. 2012; 94(1):10-19
Doi: 10.1093/cvr/cvs092
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wagner, D; Amrein, K; Dimai, HP; Kniepeiss, D; Tscheliessnigg, KH; Kornprat, P; Dobnig, H; Pieber, T; Fahrleitner-Pammer, A
Ibandronate and calcitriol reduces fracture risk, reverses bone loss, and normalizes bone turnover after LTX.
Transplantation. 2012; 93(3):331-336
Doi: 10.1097/TP.0b013e31823f7f68
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wagner, D; Kniepeiss, D; Stiegler, P; Zitta, S; Bradatsch, A; Robatscher, M; Müller, H; Meinitzer, A; Fahrleitner-Pammer, A; Wirnsberger, G; Iberer, F; Tscheliessnigg, K; Reibnegger, G; Rosenkranz, AR
The assessment of GFR after orthotopic liver transplantation using cystatin C and creatinine-based equations.
Transpl Int. 2012; 25(5):527-536
Doi: 10.1111/j.1432-2277.2012.01449.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Walsh, JB; Lems, WF; Karras, D; Langdahl, BL; Ljunggren, O; Fahrleitner-Pammer, A; Barrett, A; Rajzbaum, G; Jakob, F; Marin, F
Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS).
Calcif Tissue Int. 2012; 90(5):373-383
Doi: 10.1007/s00223-012-9590-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Short report/Letter
** Pilz, S; Meinitzer, A; Tomaschitz, A; Kienreich, K; Fahrleitner-Pammer, A; Drechsler, C; Boehm, BO; März, W
Homoarginine deficiency is associated with increased bone turnover.
Osteoporos Int. 2012; 23(11):2731-2732
Doi: 10.1007/s00198-012-1904-2
Web of Science
PubMed
FullText
FullText_MUG
Review
** Muschitz, C; Fahrleitner-Pammer, A; Huber, J; Preisinger, E; Kudlacek, S; Resch, H
Update on denosumab in postmenopausal osteoporosis--recent clinical data.
Wien Med Wochenschr. 2012; 162(17-18):374-379
Doi: 10.1007/s10354-012-0116-x
PubMed
FullText
FullText_MUG
Correspondence
** Pilz, S; Tomaschitz, A; Kienreich, K; Fahrleitner-Pammer, A; März, W
Correspondence (letter to the editor): Appeal for Vitamin D Therapy.
Dtsch Arztebl Int. 2012; 109(19): 359; author reply 359-359; author reply 360.
Doi: 10.3238/arztebl.2012.0359a
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Kocijan, R; Muschitz, C; Amrein, K; Fahrleitner-Pammer, A; Pietschmann, P; Haschka, J; Dinu, S; Resch, H;
Serum sclerostin levels, bone turnover markers and body composition in mild, moderate and severe osteogenesis imperfecta.
BONE. 2012; 51(6):S10-S11.-International Conference on Progress in Bone and Mineral Research / Annual Autumn Conference of the Austrian-Society-for-Bone-and-Mineral-Research including a Symposium on Calcium Sensing Receptor; NOV 29-DEC 01, 2012; Vienna, AUSTRIA.
Doi: 10.1016/j.bone.2012.08.029
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Muschitz, C; Fahrleitner-Pammer, A; Kocijan, R; Bittighofer, C; Trubrich, A; Kuehne, F; Waneck, R; Resch, H;
TERIPARATIDE AND ANTIRESORPTIVE COMBINATION TREATMENT SUBSEQUENT TO 9 MONTHS OF TERIPARATIDE MONOTHERAPY.
OSTEOPOROSIS INT. 2012; 23: S106-S107.-IOF-ECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd IOF-ESCEO Pre-Clinical Symposium; MAR 21-24, 2012; Bordeaux, FRANCE.
[Oral Communication]
Web of Science
** Muschitz, C; Haschka, J; Kocijan, R; Bitighofer, C; Trubrich, A; Fahrleitner-Pammer, A; Resch, H;
TREATMENT WITH PTH 1-84 IN MALE PATIENTS WITH SEVERE OSTEOPOROSIS - RESULTS FROM A PROSPECTIVE 24 MONTH OPEN-LABEL TRIAL.
OSTEOPOROSIS INT. 2012; 23: S107-S107.-IOF-ECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd IOF-ESCEO Pre-Clinical Symposium; MAR 21-24, 2012; Bordeaux, FRANCE.
[Oral Communication]
Web of Science
** Muschitz, C; Haschka, J; Kocijan, R; Bittighofer, C; Trubrich, A; Fahrleitner-Pammer, A; Resch, H;
Treatment with PTH 1-84 in male patients with severe osteoporosis - results from a prospective 24 month open-label trial.
BONE. 2012; 50: S154-S154.-39th Annual Congress of the European-Calcified-Tissue-Society (ECTS); MAY 19-23, 2012; Stockholm, SWEDEN.
Doi: 10.1016/j.bone.2012.02.481
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Muschitz, C; Haschka, J; Kocijan, R; Fahrleitner-Pammer, A; Nirnberger, G; Resch, H
TREATMENT WITH PTH 1-84 IN MALE PATIENTS WITH SEVERE OSTEOPOROSIS RESULTS FROM A PROSPECTIVE 24 MONTH OPEN-LABEL TRIAL
OSTEOPOROSIS INT. 2012; 23: 696-696.-IOF Regionals 2nd Middle East and Africa Osteoporosis Meeting / 6th Pan Arab Osteoporosis Congress (PAOC); SEP 27-OCT 01, 2012; JORDAN.
[Oral Communication]
Web of Science
** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Lung, S; Resch, H;
Overlapping and follow-up of alendronate to teriparatide treatment results in maintenance of excess BMD gain.
BONE. 2012; 51(6):S10-S10.-International Conference on Progress in Bone and Mineral Research / Annual Autumn Conference of the Austrian-Society-for-Bone-and-Mineral-Research including a Symposium on Calcium Sensing Receptor; NOV 29-DEC 01, 2012; Vienna, AUSTRIA.
Doi: 10.1016/j.bone.2012.08.028
[Keynote lecture]
Web of Science
FullText
FullText_MUG
** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Pavo, I; Lung, S; Resch, H
ANTIRESORPTIVES OVERLAPPING ONGOING TERIPARATIDE TREATMENT RESULT IN ADDITIONAL INCREASES IN BONE MINERAL DENSITY
OSTEOPOROSIS INT. 2012; 23: 695-695.-IOF Regionals 2nd Middle East and Africa Osteoporosis Meeting / 6th Pan Arab Osteoporosis Congress (PAOC); SEP 27-OCT 01, 2012; JORDAN.
[Oral Communication]
Web of Science
** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Pavo, I; Resch, H
OVERLAPPING AND FOLLOW-UP OF ALENDRONATE TO TERIPARATIDE TREATMENT RESULTS IN MAINTENANCE OF EXCESS BMD GAIN
OSTEOPOROSIS INT. . 2012; 23: 697-697.-IOF Regionals 2nd Middle East and Africa Osteoporosis Meeting / 6th Pan Arab Osteoporosis Congress (PAOC); SEP 27-OCT 01, 2012; JORDAN.
[Oral Communication]
Web of Science
** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Resch, H
OVERLAPPING AND FOLLOW-UP OF ALENDRONATE TO TERIPARATIDE TREATMENT RESULTS IN MAINTENANCE OF EXCESS BMD GAIN
OSTEOPOROSIS INT. . 2012; 23: S750-S751.-IOF Regionals - 3rd Asia-Pacific Osteoporosis Meeting; DEC 13-16, 2012; Kuala Lumpur, MALAYSIA.
[Poster]
Web of Science
** Muschitz, C; Kocijan, R; Kuehne, F; Haschka, J; Bittighofer, C; Trubrich, A; Fahrleitner-Pammer, A; Resch, H;
Teriparatide and antiresorptive combination treatment subsequent to 9 months of teriparatide monotherapy.
BONE. 2012; 50: S41-S41.-39th Annual Congress of the European-Calcified-Tissue-Society (ECTS); MAY 19-23, 2012; Stockholm, SWEDEN.
Doi: 10.1016/j.bone.2012.02.107
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Muschitz, C; Kocijan, R; Kuehne, F; Haschka, J; Bittighofer, C; Trubrich, A; Fahrleitner-Pammer, A; Resch, H;
The discriminatory capacity of clinical risk factors and bmd measurements at different skeletal sites for detect-ing patients with vertebral fractures.
BONE. 2012; 50: S147-S147.-39th Annual Congress of the European-Calcified-Tissue-Society (ECTS); MAY 19-23, 2012; Stockholm, SWEDEN.
Doi: 10.1016/j.bone.2012.02.457
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Stepan, JJ; Dobnig, H; Fahrleitner-Pammer, A; Ma, YFL; Zeng, QQ; Wan, XH; Marin, F; Pavo, I;
EFFECTS OF TERIPARATIDE ON CORTICAL HISTOMORPHOMETRIC VARIBLES IN PATIENTS RECEIVING LONG-TERM ALENDRONATE THERAPY.
OSTEOPOROSIS INT. 2012; 23: S132-S132.-IOF-ECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd IOF-ESCEO Pre-Clinical Symposium; MAR 21-24, 2012; Bordeaux, FRANCE.
[Oral Communication]
Web of Science
** Wagner, D; Kniepeiss, D; Stiegler, P; Zitta, S; Muller, H; Meinitzer, A; Fahrleitner-Pammer, A; Rosenkranz, AR
THE ASSESSMENT OF GFR AFTER ORTHOTOPIC LIVER TRANSPLANTATION USING CYSTATIN C AND CREATININE-BASED EQUATIONS
J HEPATOL. 2012; 56: S96-S96.-47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN.
Doi: 10.1016/S0168-8278(12)60242-6
[Poster]
Web of Science
FullText
FullText_MUG
2011
Full paper/article (Journal)
** Amrein, K; Dimai, HP; Dobnig, H; Fahrleitner-Pammer, A
Low bone turnover and increase of bone mineral density in a premenopausal woman with postoperative hypoparathyroidism and thyroxine suppressive therapy.
Osteoporos Int. 2011; 22(11):2903-2905
Doi: 10.1007/s00198-010-1441-9
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Amrein, K; Langmann, A; Fahrleitner-Pammer, A; Pieber, TR; Zollner-Schwetz, I
Women underrepresented on editorial boards of 60 major medical journals.
Gend Med. 2011; 8(6):378-387
Doi: 10.1016/j.genm.2011.10.007
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Dimai, HP; Svedbom, A; Fahrleitner-Pammer, A; Pieber, T; Resch, H; Zwettler, E; Chandran, M; Borgström, F
Epidemiology of hip fractures in Austria: evidence for a change in the secular trend.
Osteoporos Int. 2011; 22(2): 685-692.
Doi: 10.1007/s00198-010-1271-9
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fahrleitner-Pammer, A; Langdahl, BL; Marin, F; Jakob, F; Karras, D; Barrett, A; Ljunggren, O; Walsh, JB; Rajzbaum, G; Barker, C; Lems, WF
Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS).
Osteoporos Int. 2011; 22(10): 2709-2719.
Doi: 10.1007/s00198-010-1498-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Malliga, DE; Wagner, D; Fahrleitner-Pammer, A
The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review.
Wien Med Wochenschr. 2011; 161(23-24):565-570
Doi: 10.1007/s10354-011-0022-7
PubMed
FullText
FullText_MUG
** Wagner, D; Adunka, C; Kniepeiss, D; Jakoby, E; Schaffellner, S; Kandlbauer, M; Fahrleitner-Pammer, A; Roller, RE; Kornprat, P; Müller, H; Iberer, F; Tscheliessnigg, KH
Serum albumin, subjective global assessment, body mass index and the bioimpedance analysis in the assessment of malnutrition in patients up to 15 years after liver transplantation.
Clin Transplant. 2011; 25(4):E396-E400
Doi: 10.1111/j.1399-0012.2011.01442.x
Web of Science
PubMed
FullText
FullText_MUG
Short report/Letter
** Amrein, K; Schilcher, G; Fahrleitner-Pammer, A
Hypercalcaemia in asymptomatic sarcoidosis unmasked by a vitamin D loading dose.
Eur Respir J. 2011; 37(2): 470-471.
Doi: 10.1183/09031936.00136910
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Amrein, K; Dimai, HP; Dobnig, H; Fahrleitner-Pammer, A
POSTOPERATIVE HYPOPARATHYROIDISM, LOW BONE TURNOVER AND INCREASE IN BONE MINERAL DENSITY DESPITE THYROXINE SUPPRESSIVE THERAPY IN A PREMENOPAUSAL WOMAN
OSTEOPOROSIS INT. 2011; 22: 182-183.
[Poster]
Web of Science
** Dimai, H; Chandran, M; Svedbom, A; Thaler, H; Amrein, K; Fahrleitner-Pammer, A; Zwettler, E; Borgstrom, F
INCIDENCE OF HUMERAL FRACTURES IN AUSTRIA BETWEEN 1989 AND 2008
OSTEOPOROSIS INT. 2011; 22: 306-307.-European Congress on Osteoporosis & Osteoarthritis (ECCEO11-IOF); MAR 23-26, 2011; Valencia, SPAIN.
[Poster]
Web of Science
** Dimai, HP; Svedbom, A; Chandran, M; Amrein, K; Fahrleitner-Pammer, A; Zwettler, E; Borgstrom, F
Epidemiology of humeral fractures in Austria between 1989 and 2008
BONE. . 2011; 48: S190-S191.-3rd Joint Meeting of the European Calcified Tissue Society & the International Bone and Mineral Society; MAY 7-11, 2011;
Doi: 10.1016/j.bone.2011.03.449
[Poster]
Web of Science
FullText
FullText_MUG
** Muschitz, C; Haschka, J; Kocijan, R; Trubrich, A; Fahrleitner-Pammer, A; Nirnberger, G; Resch, H
Treatment with PTH 1-84 in male patients with severe osteoporosis - Results from a prospective 24 month open-label trial
WIEN KLIN WOCHENSCHR. . 2011; 123(17-18):A51-A51.-42. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; OCT 5-8, 2011; Innsbruck, AUSTRIA.
[Poster]
Web of Science
** Muschitz, C; Kocijan, R; Fahrleitner-Pammer, A; Bittighofer, C; Trubrich, A; Kuhne, F; Waneck, R; Resch, H
Teriparatide and antiresorptive combination treatment subsequent to 9 Months of osteoanabolic monotherapy in female patients with severe osteoporosis and prevalent fragility fractures
WIEN KLIN WOCHENSCHR. . 2011; 123(17-18):A51-A51.-42. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; OCT 5-8, 2011; Innsbruck, AUSTRIA.
[Poster]
Web of Science
** Wagner, D; Dimai, HP; Amrein, K; Dobnig, H; Kniepeiss, D; Fahrleitner, A
COMBINATION THERAPY WITH IBANDRONATE AND CALCITRIOL IS EFFECTIVE IN PATIENTS FOLLOWING LIVER TRANSPLANTATION (LTX): A THREE YEAR PROSPECTIVE CONTROLLED STUDY
TRANSPL INT. . 2011; 24: 345-345.-15th Congress of the ESOT and 22nd Annual Conference of the BSHI; SEP 4-7, 2011; Glasgow, UK.
[Poster]
Web of Science
** Wagner, D; Dobnig, H; Tscheliessnigg, K; Prenner, G; Wasler, A; Piswagner-Solkner, C; Kniepeiss, D; Fahrleinter, A
TESTOSTERONE REPLACEMENT IN CARDIAC TRANSPLANT PATIENTS ON TOP OF BISPHOSPHONATE THERAPY EXERTS MULTIPLE BENEFITS ON BONE MASS, LIBIDO AND SEXUAL ACTIVITY
TRANSPL INT. 2011; 24: 332-332.
[Oral Communication]
Web of Science
** Wagner, D; Telsnig, B; Kniepeiss, D; Jakoby, E; Schaffellner, S; Fahrleitner-Pammer, A; Wasler, A; Roller, R; Tscheliessnigg, K
THE ROLE OF SERUM ALBUMIN (SA) IN THE PREDICTION OF MALNUTRITION IN PATIENT AT LEAST ONE HEART TRANSPLANTATION (HTX)
TRANSPL INT. 2011; 24: 270-271.
[Poster]
Web of Science
2010
Full paper/article (Journal)
** Dimai, HP; Pietschmann, P; Resch, H; Preisinger, E; Fahrleitner-Pammer, A; Dobnig, H; Klaushofer, K; Austrian Society for Bone and Mineral Research (AuSBMR)
Austrian guidance for the pharmacologic treatment of osteoporosis in postmenopausal women: Addendum 2010].
Wien Med Wochenschr. 2010; 160(21-22):586-589
Doi: 10.1007/s10354-010-0840-z
PubMed
FullText
FullText_MUG
** Pietschmann, P; Azizi-Semrad, U; Pils, K; Fahrleitner-Pammer, A; Resch, H; Dobnig, H
Pharmacologic undertreatment of osteoporosis in Austrian nursing homes and senior's residences.
Wien Klin Wochenschr. 2010; 122(17-18): 532-537.
Doi: 10.1007/s00508-010-1428-8
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Reid, I; Miller, P; Brown, J; Kendler, D; Fahrleitner-Pammer, A; Valter, I; Maasalu, K; Bolognese, M; Woodson, G; Bone, H; Ding, B; Wagman, R; Martin, JS; Ominsky, M; Dempster, D; on behalf of the Denosumab Phase 3 Bone Histology Study Group
Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies.
J Bone Miner Res. 2010; 25(10): 2256-2265.
Doi: 10.1002/jbmr.149
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sampl, E; Wagner, D; Friedl, C; Dobnig, H; Fahrleitner-Pammer, A
Vitamin D deficiency following Billroth II surgery - How much vitamin D is enough?: a case report.
Cases J. 2010; 3(1):12-12
Doi: 10.1186/1757-1626-3-12
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Stepan, JJ; Burr, DB; Li, J; Ma, YL; Petto, H; Sipos, A; Dobnig, H; Fahrleitner-Pammer, A; Michalská, D; Pavo, I
Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis.
Osteoporos Int. 2010; 21(12): 2027-2036.
Doi: 10.1007/s00198-009-1168-7
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Tomaschitz, A; Maerz, W; Pilz, S; Ritz, E; Scharnagl, H; Renner, W; Boehm, BO; Fahrleitner-Pammer, A; Weihrauch, G; Dobnig, H
Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range.
J Am Coll Cardiol. 2010; 55(19): 2171-2180.
Doi: 10.1016/j.jacc.2010.01.032
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Wagner, D; Fahrleitner-Pammer, A
Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help?
Wien Med Wochenschr. 2010; 160(17-18): 452-457.
Doi: 10.1007/s10354-010-0818-x
PubMed
FullText
FullText_MUG
** Wagner, D; Iberer, F; Sereinigg, M; Kniepeiss, D; Kornprat, P; Fahrleitner-Pammer, A; Stiegler, P; Tscheliessnigg, K
Massive diaphragmatic herniation following orthotopic liver transplantation in an adult.
Liver Transpl. 2010; 16(6):783-785
Doi: 10.1002/lt.22079
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wagner, D; Kniepeiss, D; Schaffellner, S; Jakoby, E; Mueller, H; Fahrleitner-Pammer, A; Tscheliessnigg, KH; Iberer, F
Sirolimus has a potential to influent viral recurrence in HCV positive liver transplant candidates.
Int Immunopharmacol. 2010; 10(8): 990-993.
Doi: 10.1016/j.intimp.2010.05.006
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Dobnig, H; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Kinkeldei, J; Bohm, B; Fahrleitner-Pammer, A; Marz, W
INFLUENCE OF 25-HYDROXYVITAMIN D STATUS ON SERUM PARATHYROID HORMONE LEVELS VARIES WITH KDOQI CLASSIFICATION OF RENAL FUNCTION AND IS INDEPENDENT OF 1,25 DIHYDROXYVITAMIN D CONCENTRATIONS
OSTEOPOROSIS INT. 2010; 21: 11-11. -IOF World Congress on Osteoporosis 10Th European Congress on Clinical an Economic Aspects of Osteoporosis and Osteoarthritis ; 5-8 May ; Florence, Italy.
[Oral Communication]
Web of Science
FullText
** Fahrleitner-Pammer, A; Ljunggren, O; Langdahl, B; Walsh, B; Barker, C; Lems, W; Karras, D; Rajzbaum, G; Jakob, F; Barrett, A; Marin, F
CHANGES IN QUALITY OF LIFE AND BACK PAIN IN WOMEN WITH OSTEOPOROSIS TREATED WITH RHPTH(1-34) (TERIPARATIDE): 36 MONTH RESULTS FROM THE EUROPEAN FORSTEO OBSERVATIONAL STUDY (EFOS)
OSTEOPOROSIS INT. 2010; 21: 156-157. -IOF World Congress on Osteoporosis tenth European Congress on Clinical and Economic Aspects of Osteoporosis and osteoarthritis; 5-8 may 2010; Florence, Italy.
[Poster]
Web of Science
FullText
** Fruhwald, FM; Fahrleitner-Pammer, A; Wagner, D; Haas, J; Erdmann, E; Tavazzi, L; Schoppet, M; Cleland, JGF
Prognostic impact of serum osteoprotegerin, NT-pro-BNP and big endothelin levels in patients with heart failure and ventricular dysynchrony. Results from the CARE-HF study.
Eur Heart J2010; 31: 1048-1048.-ESC congress 2010; Aug 28 - Sep 1, 2010; Stockholm, Schweden.
[Poster]
Web of Science
** Reid, I; Miller, P; Brown, JP; Kendler, D; Fahrleitner-Pammer, A; Valter, I; Maasalu, K; Bolognese, M; Woodson, G; Bone, HG; Ding, B; Wagman, RB; San Martin, J; Ominsky, MS; Dempster, DW
EFFECT OF DENOSUMAB TREATMENT ON BONE HISTOLOGY AND HISTOMORPHOMETRY: THE FREEDOM AND STAND STUDIES
OSTEOPOROSIS INT. 2010; 21: 134-134. -11.-IOF World Congress on Osteoporosis 10Th European Congress on Clinical an Economic Aspects of Osteoporosis and Osteoarthritis ; 5-8 May ; Florence, Italy.
[Poster]
Web of Science
FullText
** Wagner, D; Adunka, C; Kaindlbauer, M; Kniepess, D; Schaffellner, S; Jakoby, E; Iberer, F; Roller-Wirnsberger, R; Fahrleitner-Pammer, A; Tscheliessnigg, KH
Comparison of Antrophometric Measurements, Laboratory Parameters and Bio Impedance Analysis in the Assessment of Malnutrition in Patients 5, 10 and 15 Years after Liver Transplantation
LIVER TRANSPLANT. 2010; 16(6):S248-S248.-Meeting of the International Liver Transplantation Society; JUN 10-16; Hongkong, CHINA.
[Poster]
Web of Science
** Wagner, D; Dobnig, H; Iberer, F; Prenner, G; Kniepeiss, D; Leb, G; Tscheliessnig, KH; Piswanger, C; Fahrleitner, A
Combination Therapy with Ibandronate and Calcitrol Is Efffective in Patients Following Liver Transplantation (LTX): A Three Year Prospective Controlled Study
LIVER TRANSPLANT. 2010; 16(6):S248-S248.
[Poster]
Web of Science
** Wagner, D; Dobnig, H; Kniepeiss, D; Iberer, F; Schaffellner, S; Tscheliessnigg, K; Pieber, T; Fahrleitner, A
Combination Therapy with Ibandronate and Calcitrol Is Efffective in Patients Following Liver Transplantation (LTX): A Three Year Prospective Controlled Study
AM J TRANSPLANT. 2010; 10: 157-158.
[Oral Communication]
Web of Science
** Wagner, D; Dobnig, H; Kniepeiss, D; Iberer, F; Tscheliessnigg, K; Pieber, T; Obermayer, B; Trauner, M; Fahrleitner, A
Vitamin D Deficiency, Hyperparathyroidism and Bone Turnover in Patients Listed for Liver Transplantation (LTX).
AM J TRANSPLANT. 2010; 10: 350-350.-Annual Meeting of the American Society of Transplantation; MAY 2-8; San Diego, California.
[Oral Communication]
Web of Science
Comment
** Dimai, HP; Svedbom, A; Fahrleitner-Pammer, A; Pieber, T; Resch, H; Zwettler, E; Chandran, M; Borgström, F
Reversal in the secular trend of hip fracture incidences in Austria.
Wien Klin Wochenschr. 2010; 122(11-12): 380-381.
Doi: 10.1007/s00508-010-1387-0
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Wagner, D; Kniepeiss, D; Iberer, F; Fahrleitner-Pammer, A; Kornprat, P; Tscheliessnigg, K
Reply.
Liver Transpl. 2010; 16(10): 1221-1221.
Doi: 10.1002/lt.22171
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
2009
Full paper/article (Journal)
** Berger, R; Shankar, A; Fruhwald, F; Fahrleitner-Pammer, A; Freemantle, N; Tavazzi, L; Cleland, JG; Pacher, R
Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.
Eur Heart J. 2009; 30(17): 2109-2116.
Doi: 10.1093/eurheartj/ehp210
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Cummings, SR; San Martin, J; McClung, MR; Siris, ES; Eastell, R; Reid, IR; Delmas, P; Zoog, HB; Austin, M; Wang, A; Kutilek, S; Adami, S; Zanchetta, J; Libanati, C; Siddhanti, S; Christiansen, C; FREEDOM Trial
Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
N Engl J Med. 2009; 361(8): 756-765.
Doi: 10.1056/NEJMoa0809493
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dimai, HP; Pietschmann, P; Resch, H; Preisinger, E; Fahrleitner-Pammer, A; Dobnig, H; Klaushofer, K; Austrian Society for Bone and Mineral Research (AuSBMR)
Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009
Wien Med Wochenschr Suppl. 2009; (122): 1-34.
Doi: 10.1007/s10354-009-0656-x
PubMed
FullText
FullText_MUG
Google Scholar
** Dobnig, H; Stepan, JJ; Burr, DB; Li, J; Michalská, D; Sipos, A; Petto, H; Fahrleitner-Pammer, A; Pavo, I
Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated With Alendronate *
J Bone Miner Res. 2009; 24(12): 1998-2006.
Doi: 10.1359/jbmr.090527
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fahrleitner-Pammer, A; Dobnig, H; Dimai, HP; Holzer, H; Benesch, T; Borchhardt, K; Cejka, D; Haas, M
The effect of RANKL and OPG on bone mineral density in pre-dialysis chronic renal failure.
Clin Nephrol. 2009; Volume 71(June): 652-659.
Doi: 10.5414/CNP71652
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fahrleitner-Pammer, A; Piswanger-Soelkner, JC; Pieber, TR; Obermayer-Pietsch, BM; Pilz, S; Dimai, HP; Prenner, G; Tscheliessnigg, KH; Hauge, E; Portugaller, RH; Dobnig, H
Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial.
J Bone Miner Res. 2009; 24(7): 1335-1344.
Doi: 10.1359/jbmr.090216
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Langdahl, BL; Rajzbaum, G; Jakob, F; Karras, D; Ljunggren, O; Lems, WF; Fahrleitner-Pammer, A; Bernard Walsh, J; Barker, C; Kutahov, A; Marin, F
Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS).
Calcif Tissue Int. 2009; 85(6): 484-493.
Doi: 10.1007/s00223-009-9299-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Tomaschitz, A; Stepan, V; Obermayer-Pietsch, B; Fahrleitner-Pammer, A; Schweighofer, N; Portugaller, HR; Sourij, H; Dobnig, H; Meinitzer, A; Pieber, TR
Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism.
BMC Endocr Disord. 2009; 9(2):11-11
Doi: 10.1186/1472-6823-9-11
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Dobnig, H; Pilz, S; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Fahrleitner-Pammer, A; Bohm, BO; Marz, W
25-hydroxyvitamin D levels and association with all-cause mortality in patients with type 2 diabetes mellitus
DIABETOLOGIA. 2009; 52: 316--44th General Assembly of the European Association for the Study of Diabetes (EASD); SEP 7-11, 2009; Rome, ITALY.
[Poster]
Web of Science
** Dobnig, H; Pilz, S; Scharnagl, H; Renner, W; Seelhorst, U; Wellnitz, B; Kinkeldei, J; Bohm, B; Fahrleitner-Pammer, A; Marz, W
Influence of 25-hydroxyvitamin D and 1,25 dihydroxyvitamin D status on serum parathyroid hormone levels varies at different levels of renal function
BONE. 2009; 44(2):S360-S360.-36th European Symposium on Calcified Tissue; MAY 23-27, 2009; Vienna, Austria.
Doi: 10.1016/j.bone.2009.03.193
[Poster]
Web of Science
FullText
FullText_MUG
** Fahrleitner-Pammer, A; Piswanger-Soelkner, JC; Obermayer-Pietsch, BM; Friedl, C; Prenner, G; Tscheliessnigg, K; Dobnig, H
Testosterone replacement in combination with bisphosphonate therapy in male cardiac transplant patients exerts additional benefits on bone mass: A 5-year prospective study
BONE. 2009; 44(2):S424-S424.-ECTS; June 2009; Vienna; Austria.
Doi: 10.1016/j.bone.2009.03.362
[Poster]
Web of Science
FullText
FullText_MUG
** Lems, W; Marin, F; Langdahl, B; Karras, D; Barrett, A; Walsh, B; Fahrleitner-Pammer, A; Rajzbaum, G; Barker, C; Jakob, F
FRACTURE INCIDENCE, QUALITY OF LIFE AND BACK PAIN IN WOMEN WITH OSTEOPOROSIS PRETREATED WITH BISPHOSPHONATES: 18 MONTH RESULTS FROM THE EUROPEAN FORSTEO OBSERVATIONAL STUDY (EFOS)
OSTEOPOROSIS INT. 2009; 20: 75-75.
[Poster]
Web of Science
** Lems, WF; Karras, D; Langdahl, BL; Ljunggren, O; Walsh, JB; Barker, C; Fahrleitner-Pammer, A; Barrett, A; Rajzbaum, G; Jakob, F; Marin, F
Fracture incidence, quality of life and back pain in women with osteoporosis and concomitant glucocorticoid use treated with teriparatide: 18-month results from the European Forsteo Observational Study
BONE. 2009; 44(2):S448-S449.-ECTS; June 2009; Vienna; Austria.
Doi: 10.1016/j.bone.2009.03.421
[Poster]
Web of Science
FullText
FullText_MUG
** Stocker, P; Wehr, E; Schweighofer, N; Fahrleitner-Pammer, H; Dobnig, H; Pieber, TR; Obermayer-Pietsch, B
Senseing polymorphisms of the calcium receptor and its possible clinical relevance
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A20-A20.
[Poster]
Web of Science
** Wagner, D; Dobnig, H; Kniepeiss, D; Iberer, F; Pieber, TR; Obermayer-Pietsch, BM; Trauner, M; Fahrleitner-Pammer, A
Vitamin D deficiency, hyperparathyroidism and bone turnover in patients listed for liver transplantation (LTX): Preliminary results of a cross-sectional study
BONE. 2009; 44(2):S400-S400.-ECTS; June 2009; Vienna; Austria.
Doi: 10.1016/j.bone.2009.03.301
[Poster]
Web of Science
FullText
FullText_MUG
Full paper/article (Proceedings)
** Pfeifer, M; Begerow, B; Minne, HW; Suppan, K; Fahrleitner-Pammer, A; Dobnig, H
Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals.
Osteoporos Int. 2009; 20(2): 315-322.
Doi: 10.1007/s00198-008-0662-7
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2008
Full paper/article (Journal)
** Langdahl, BL; Uitterlinden, AG; Ralston, SH; Trikalinos, TA; Balcells, S; Brandi, ML; Scollen, S; Lips, P; Lorenc, R; Obermayer-Pietsch, B; Reid, DM; Armas, JB; Arp, PP; Bassiti, A; Bustamante, M; Husted, LB; Carey, AH; Pérez Cano, R; Dobnig, H; Dunning, AM; Fahrleitner-Pammer, A; Falchetti, A; Karczmarewicz, E; Kruk, M; van Leeuwen, JP; Masi, L; van Meurs, JB; Mangion, J; McGuigan, FE; Mellibovsky, L; Mosekilde, L; Nogués, X; Pols, HA; Reeve, J; Renner, W; Rivadeneira, F; van Schoor, NM; Ioannidis, JP; APOSS investigators; DOPS investigators; EPOS investigators; EPOLOS investigators; FAMOS investigators; LASA investigators; ERGO investigators; for the GENOMOS Study
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study.
Bone. 2008; 42(5): 969-981.
Doi: 10.1016/j.bone.2007.11.007
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Pilz, S; Dobnig, H; Fahrleitner-Pammer, A; Polt, G; Marz, W
Vitamin D deficiency: a global health problem
LABORATORIUMSMEDIZIN. 2008; 32(4):
Doi: 10.1515/JLM.2008.039et
Web of Science
FullText
FullText_MUG
** Pilz, S; März, W; Wellnitz, B; Seelhorst, U; Fahrleitner-Pammer, A; Dimai, HP; Boehm, BO; Dobnig, H
Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography.
J Clin Endocrinol Metab. 2008; 93(10): 3927-3935.
Doi: 10.1210/jc.2008-0784
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Rajzbaum, G; Jakob, F; Karras, D; Ljunggren, O; Lems, WF; Langdahl, BL; Fahrleitner-Pammer, A; Walsh, JB; Gibson, A; Tynan, AJ; Marin, F
Characterization of patients in the European Forsteo Observational Study (EFOS): postmenopausal women entering teriparatide treatment in a community setting.
Curr Med Res Opin. 2008; 24(2): 377-384.
Doi: 10.1185/030079908X261087
Web of Science
PubMed
FullText
FullText_MUG
Review
** Pilz, S; Dobnig, H; Fahrleitner-Pammer, A; Polt, G; März, W
Vitamin D deficiency: a global health problem
Journal of Laboratory Medicine. 2008; 32(4): 200-208.
Doi: 10.1515/JLM.2008.039
Web of Science
FullText
FullText_MUG
Abstract (Journal)
** Fahrleitner-Pammer, A; Obermayer-Pietsch, B; Schweiger, M; Prenner, G; Tscheliessnigg, K.H; Piswanger-Sölkner, J.C; Dimai, H.P; Dobnig, H.
Replacing testosterone in male cardiac transplant patients exerts multiple benefits on bone mass, libido and sexual activity: A 5-year prospective study.
. 2008; 23: S471
[Poster]
Web of Science
** Fahrleitner-Pammer, A; Piswanger-Solkner, JC; Obermayer-Pietsch, B; Friedl, C; Dobnig, H
Testosteron substitution in a men with a heart graft with hypogonadism shows positive effects on bones metabolism, on Libido and sexual life: A 5 years long lasting controlled study
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A40-A40.-ÖGIM; 17.-21.9.2008; Graz.
[Poster]
Web of Science
** Friedl, C; Dobnig, H; Piswanger-Solkner, JC; Obermayer-Pietsch, B; Fahrleitner-Pammer, A
Vitamin D3 and muscular strength: Prospective analyze of 832 occupants of a nursery home in Austria
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A40-A40.
[Poster]
Web of Science
** Langdahl, B; Ljunggren, O; Lems, W; Walsh, B; Barker, C; Fahrleitner-Pammer, A; Karras, D; Rajzbaum, G; Jakob, F; Kutahov, A; Marin, F
Fracture incidence and changes in quality of life and back pain in women with osteoporosis treated with rhpth(I-34) (teriparatide): 18 month results from the European Forsteo Observational Study (EFOS)
CALCIFIED TISSUE INT. 2008; 82: S158-S158.-ECTS; June 2008; Barcelona.
[Oral Communication]
Web of Science
** Langdahl, B; Ljunggren, Ö; Lems, W; Walsh, B.j; Barker, C; Fahrleitner-Pammer, A; Karras, D; Marin, F;
Women with severe Osteoporosis treated with rhPTH(1-34)(teriparatide) improve Quality of life regardles of incident fractures: 18 month results from the European Forsteo Observational Study (EFOS).
. 2008; 23: S347
[Poster]
Web of Science
** Lems, W; Langdahl, B; Ljunggren, O; Kutahov, A; Karras, D; Walsh, JB; Fahrleitner-Pammer, A; Rajzbaum, G; Barket, C; Jakob, F; Marin, F
Fracture incidence, quality of life and back pain in women with osteoporosis pretreated with bisphosphonates: 18 month results from the European forsteo, observational study (EFOS)
ARTHRITIS RHEUM. 2008; 58(9):S737-S738.-72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals; OCT 24-29, 2008; San Francisco, CA.
[Oral Communication]
Web of Science
** Ljunggren, O; Fahrleitner-Pammer, A; Kutahov, A; Walsh, JB; Langdahl, B; Jakob, F; Lems, W; Rajzbaum, G; Barker, C; Karras, D; Marin, F
Back Pain is Reduced in Postmenopausal Women with Severe Osteoporosis Treated with rhPTH(1-34) (teriparatide) Regardless of Incident Fractures: 18 Month Results from the European Forsteo Observational Study (EFOS).
J BONE MINER RES. 2008; 23: S347-S347.-30th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research; SEP 12-16, 2008; Montreal, CANADA.
[Oral Communication]
Web of Science
** Obermayer-Pietsch, BM; Meilinger, M; Wehr, E; Schweighofer, N; Fahrleitner-Pammer, A; Dobnig, H; Pietschmann, P; Kudlacek, S; Friedrich, G; Gugatschka, M
Hypogonadism and bone in men: Impact of body weight in a follow-up over 4 years
CALCIFIED TISSUE INT. 2008; 82: S160-S160.-ECTS; June 2008; Barcelona.
[Poster]
Web of Science
Full paper/article (Proceedings)
** Fahrleitner-Pammer, A; Herberth, J; Browning, SR; Obermayer-Pietsch, B; Wirnsberger, G; Holzer, H; Dobnig, H; Malluche, HH
Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease
J BONE MINER RES. 2008; 23(11): 1850-1858.
Doi: 10.1359/jbmr.080610
[Poster]
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2007
Full paper/article (Journal)
** Dobnig, H; Piswanger-Sölkner, JC; Obermayer-Pietsch, B; Tiran, A; Strele, A; Maier, E; Maritschnegg, P; Riedmüller, G; Brueck, C; Fahrleitner-Pammer, A
Hip and nonvertebral fracture prediction in nursing home patients: role of bone ultrasound and bone marker measurements.
J Clin Endocrinol Metab. 2007; 92(5): 1678-1686.
Doi: 10.1210/jc.2006-2079
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fruhwald, FM; Fahrleitner-Pammer, A; Berger, R; Leyva, F; Freemantle, N; Erdmann, E; Gras, D; Kappenberger, L; Tavazzi, L; Daubert, JC; Cleland, JG
Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.
Eur Heart J. 2007; 28(13):1592-1597
Doi: 10.1093/eurheartj/ehl505
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gugatschka, M; Hoeller, A; Fahrleitner-Pammer, A; Dobnig, H; Pietschmann, P; Kudlacek, S; Obermayer-Pietsch, B
Calcium supply, bone mineral density and genetically defined lactose maldigestion in a cohort of elderly men.
J Endocrinol Invest. 2007; 30(1): 46-51.
Doi: 10.1007/BF03347395
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Lyles, KW; Colón-Emeric, CS; Magaziner, JS; Adachi, JD; Pieper, CF; Mautalen, C; Hyldstrup, L; Recknor, C; Nordsletten, L; Moore, KA; Lavecchia, C; Zhang, J; Mesenbrink, P; Hodgson, PK; Abrams, K; Orloff, JJ; Horowitz, Z; Eriksen, EF; Boonen, S; for the HORIZON Recurrent Fracture Trial
Zoledronic Acid in Reducing Clinical Fracture and Mortality after Hip Fracture.
N Engl J Med. 2007; 357(1):nihpa40967-nihpa40967
Doi: 10.1056/NEJMe074941
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Obermayer-Pietsch, BM; Gugatschka, M; Reitter, S; Plank, W; Strele, A; Walter, D; Bonelli, C; Goessler, W; Dobnig, H; Högenauer, C; Renner, W; Fahrleitner-Pammer, A
Adult-type hypolactasia and calcium availability: decreased calcium intake or impaired calcium absorption?
Osteoporos Int. 2007; 18(4): 445-451.
Doi: 10.1007/s00198-006-0251-6
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Stepan, JJ; Burr, DB; Pavo, I; Sipos, A; Michalska, D; Li, J; Fahrleitner-Pammer, A; Petto, H; Westmore, M; Michalsky, D; Sato, M; Dobnig, H
Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis.
Bone. 2007; 41(3): 378-385.
Doi: 10.1016/j.bone.2007.04.198
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Brueck, CC; Dobnig, H; Obermayer-Pietsch, BM; Fahrleitner-Pammer, A
High serum osteoprotegerin but low bone mass in patients with peripheral arterial disease (PAD)
EXP CLIN ENDOCRINOL DIABETES. 2007; 115: S88-S88.-IOF; June 2007; Montreal Canada.
[Oral Communication]
Web of Science
** Brueck, CC; Rienmuller, R; Riedmueller, G; Benedikt, M; Kovaleva, K; Gerdova, J; Fahrleitner-Pammer, A; Obermayer-Pietsch, B; Dobnig, H
Acid-base metabolism is independently correlated to bone turnover
EXP CLIN ENDOCRINOL DIABETES. 2007; 115: S88-S88.-DGE; Sakzburg.
[Poster]
Web of Science
** Dobnig, H; Stepan, JJ; Burr, DB; Fahrleitner-Pammer, AF; Li, J; Sipos, A; Sato, M; Pavo, I
Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate
J BONE MINER RES. 2007; 22: S28-S28.-Asbmr ; September; Honolulu Hawai.
[Poster]
Web of Science
** Li, J; Burr, DB; Stepan, JJ; Dobnig, H; Fahrleitner-Pammer, A; Sipos, A; Mullamey, T; Westmore, M; Sato, M; Pavo, I
Teriparatide improves bone microarchitecture in postmenopausal women previously treated with alendronate
J BONE MINER RES. 2007; 22: S28-S28.-Asbmr; September; Honolulu Hawai.
[Poster]
Web of Science
** Meilinger, M; Schweighofer, N; Forjanics, A; Dobnig, H; Fahrleitner-Pammer, A; Obermayer-Pietsch, B
Autoimmune thyroid disease, genetic predisposition and environment - case-control family studies
EXP CLIN ENDOCRINOL DIABETES. 2007; 115: S60-S60.
[Poster]
Web of Science
** Obermayer-Pietsch, B; Gugatschka, M; Groselj-Strele, A; Goessler, W; Dobnig, H; Hoegenauer, C; Fahrleitner-Pammer, A; Renner, W
Genetically defined adult-type hypolactasia and calcium balance: High amounts of lactose decrease calcium absorption
EXP CLIN ENDOCRINOL DIABETES. 2007; 115: S7-S7.
[Poster]
Web of Science
** Riedmueller, G; Wascher, TC; Brueck, CC; Gerdova, J; Breuss, B; Obermayer-Pietsch, B; Fahrleitner-Pammer, A; Dobnig, H
PTH - a new cardiovascular risk factor?
EXP CLIN ENDOCRINOL DIABETES. ; 115: S87-S88.
[Poster]
Web of Science
2006
Full paper/article (Journal)
** Braunschweig, F; Fahrleitner-Pammer, A; Mangiavacchi, M; Ghio, S; Fotuhi, P; Hoppe, UC; Linde, C
Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure.
Eur J Heart Fail. 2006; 8(8): 797-803.
Doi: 10.1016/j.ejheart.2006.03.002
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dobnig, H; Hofbauer, LC; Viereck, V; Obermayer-Pietsch, B; Fahrleitner-Pammer, A
Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients.
Osteoporos Int. 2006; 17(5):693-703
Doi: 10.1007/s00198-005-0035-4
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Dobnig, H; Piswanger-Sölkner, JC; Roth, M; Obermayer-Pietsch, B; Tiran, A; Strele, A; Maier, E; Maritschnegg, P; Sieberer, C; Fahrleitner-Pammer, A
Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk.
J Clin Endocrinol Metab. 2006; 91(9):3355-3363
Doi: 10.1210/jc.2006-0460
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Herberth, J; Fahrleitner-Pammer, A; Obermayer-Pietsch, B; Krisper, P; Holzer, H; Malluche, HH; Dobnig, H
Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease.
Clin Nephrol. 2006; 65(5):328-334
Doi: 10.5414/CNP65328
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Uitterlinden, AG; Ralston, SH; Brandi, ML; Carey, AH; Grinberg, D; Langdahl, BL; Lips, P; Lorenc, R; Obermayer-Pietsch, B; Reeve, J; Reid, DM; Amedei, A; Amidei, A; Bassiti, A; Bustamante, M; Husted, LB; Diez-Perez, A; Dobnig, H; Dunning, AM; Enjuanes, A; Fahrleitner-Pammer, A; Fang, Y; Karczmarewicz, E; Kruk, M; van Leeuwen, JP; Mavilia, C; van Meurs, JB; Mangion, J; McGuigan, FE; Pols, HA; Renner, W; Rivadeneira, F; van Schoor, NM; Scollen, S; Sherlock, RE; Ioannidis, JP; APOSS Investigators; EPOS Investigators; EPOLOS Investigators; FAMOS Investigators; LASA Investigators; Rotterdam Study Investigators; GENOMOS Study
The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis.
Ann Intern Med. 2006; 145(4):255-264
Doi: 10.7326/0003-4819-145-4-200608150-00005
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Dobnig, H; Piswanger-Solkner, C; Maier, L; Obermayer-Pietsch, B; Strele, A; Tiran, A; Brueck, C; Fahrleitner-Pammer, A
Prediction of hip- and non-vertebral fractures in nursing home patients: Role of bone ultrasound and bone turnover measurements
BONE. ; 39(5):S22-S22.
[Poster]
Web of Science
** Fahrleitner-Pammer, A; Dobnig, H
Treatment of post-transplantation bone disease: Clinical and economic aspects
OSTEOPOROSIS INT. 2006; 17: S3-S3.-Ecceo; 25. - 28. Februar Wien; vienna austria.
[Oral Communication]
Web of Science
** Fahrleitner-Pammer, A; Piswanger-Solkner, C; Obermayer-Pietsch, B; Prenner, G; Tscheliessnigg, KH; Dobnig, H
Intravenous Ibandronate effectively prevents bone loss and minimizes fracture risk in patients following cardiac transplantation: A prospective randomized placebo controlled study
BONE. 2006; 39(5):S24-S25.-American Endocrine Society; June 2006; Toronto Canada.
[Oral Communication]
Web of Science
** Lems, W; Rajzbaum, G; Marin, F; Fahrleitner, A; Karras, D; Langdahl, B; Walsh, JB; Ljunggren, O; Cleall, S; Tynan, A
Baseline characteristics of subjects enrolled in a teriparatide observational study in Europe.
ARTHRITIS RHEUM. 54(9):S588-S588.
[Poster]
Web of Science
** Obermayer-Pietsch, B; Bonelli, CM; Strele, A; Hodl, AK; Dobnig, H; Fahrleitner-Pammer, A; Kapfhammer, HP; Bonelli, RM
Bone mineral density in Huntington's disease is depending on CAG repeats in the neurotrophic Huntingtin gene, but not on weight or medication
BONE. 39(5):S8-S8.
[Poster]
Web of Science
** Schweighofer, N; Fahrleitner-Pammer, A
From bone biopsy to copy numbers - Quantitation of bone turnover regulators via real time PCR
BONE. 39(5):S37-S37.
[Poster]
Web of Science
** Walsh, JB; Cleall, S; Fahrleitner, A; Karras, D; Langdahl, B; Lems, W; Ljunggren, O; Marin, F; Raizbaum, G; Tynan, AJ
Quality of life and back pain in the European Forsteo observational study - EFOS.
J BONE MINER RES. 21: S305-S305.
[Poster]
Web of Science
2005
Full paper/article (Journal)
** Cleland, JG; Daubert, JC; Erdmann, E; Freemantle, N; Gras, D; Kappenberger, L; Tavazzi, L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators (with Fahrleitner, A)
The effect of cardiac resynchronization on morbidity and mortality in heart failure.
N Engl J Med. 2005; 352(15): 1539-1549.
Doi: 10.1056/NEJMoa050496
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dobnig, H; Sipos, A; Jiang, Y; Fahrleitner-Pammer, A; Ste-Marie, LG; Gallagher, JC; Pavo, I; Wang, J; Eriksen, EF
Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy.
J Clin Endocrinol Metab. 2005; 90(7):3970-3977
Doi: 10.1210/jc.2003-1703
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fahrleitner-Pammer, A; Obernosterer, A; Pilger, E; Dobnig, H; Dimai, HP; Leb, G; Kudlacek, S; Obermayer-Pietsch, BM
Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease.
OSTEOPOROSIS INT. 2005; 16(3): 319-324.
Doi: 10.1007/s00198-004-1693-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Gugatschka, M; Dobnig, H; Fahrleitner-Pammer, A; Pietschmann, P; Kudlacek, S; Strele, A; Obermayer-Pietsch, B
Molecularly-defined lactose malabsorption, milk consumption and anthropometric differences in adult males.
QJM. 2005; 98(12):857-863
Doi: 10.1093/qjmed/hci140
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Obermayer-Pietsch, BM; Gugatschka, M; Strele, A; Fahrleitner-Pammer, A; Dobnig, H; Kudlacek, S; Pietschmann, P; Renner, W
Osteoporosis and genetic disposition for primary adult lactose intolerance in men
BONE. 36: S252-S252.-2nd Joint Meeting of the European-Calcified-Tissue-Society/International-Bone-and-Mineral-Society; JUN 25-29, 2005; Geneva, SWITZERLAND.
Web of Science
** Obermayer-Pietsch, BM; Gugatschka, M; Strele, A; Reitter, S; Plank, W; Fahrleitner-Pammer, A; Dobnig, H; Goessler, W; Renner, W
Lactose intolerance and skeletal calcium balance - Decreased calcium intake or impaired calcium resorption?
J BONE MINER RES. 20: S391-S391.-27th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research; SEP 23-27, 2005; Nashville, TN.
Web of Science
2004
Full paper/article (Journal)
** Obermayer-Pietsch, BM; Bonelli, CM; Walter, DE; Kuhn, RJ; Fahrleitner-Pammer, A; Berghold, A; Goessler, W; Stepan, V; Dobnig, H; Leb, G; Renner, W
Genetic predisposition for adult lactose intolerance and relation to diet, bone density, and bone fractures.
J BONE MINER RES. 2004; 19(1): 42-47.
Doi: 10.1359/JBMR.0301207
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Short report/Letter
** Obermayer-Pietsch, BM; Bonelli, CM; Walter, D; Fahrleitner, A; Stepan, V; Dobnig, H; Leb, G; Renner, W
Genetic components of lactose intolerance and community frequency
J BONE MINER RES. 2004; 19: 1747-1747.
Doi: 10.1359/JBMR.040802
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Dimai, HP; Fahrleitner, A; Piswanger-Soelkner, C; Ramschak-Schwarzer, S; Obermayer-Pietsch, B; Leb, G
A new hormonal upstream factor in the RANKL/OPG system? Effects of the thyroid stimulating hormone TSH in humans
J BONE MINER RES 2004 19: S414-S414.
Web of Science
** Dimai, HP; Piswanger-Soelkner, C; Fahrleitner, A; Ramschak-Schwarzer, S; Wenisch, H; Gugatschka, M; Obermayer-Pietsch, B; Leb, G
Another hormonal upstream factor in the OPG/RANKL system? Effects of the thyroid stimulating hormone TSH on bone metabolism
OSTEOPOROSIS INT 2004 15: S16-S17.
Web of Science
** Fahrleitner-Pammer, A; Maier, E; Eichhorn, T; Graebe, A
Postmenopausal women with osteoporosis are compliant and satisfied with daily raloxifene treatment: Results from a six-month Austrian observational study
OSTEOPOROSIS INT 2004 15: S114-S114.
Web of Science
** Fahrleitner-Pammer, A; Prenner, G; Kniepeiss, D; Tschelissnigg, K; Leb, G; Piswanger-Solkner, CJ; Obermayer-Pietsch, BM; Dobnig, H
Combination therapy with ibandronate and calcitriol is effective in patients following liver transplantation: A three year prospective controlled study.
J BONE MINER RES 2004 19: S475-S475.
Web of Science
** Obermayer-Pietsch, BM; Bonelli, CM; Walter, DE; Kuhn, RJ; Fahrleitner-Pammer, A; Berghold, A; Stepan, V; Dobnig, H; Leb, G; Renner, W
GENETIC DISPOSITION FOR ADULT LACTOSE INTOLERANCE AND RELATION TO BONE PROPERTIES AND FRACTURES DURING LIFETIME
CALCIFIED TISSUE INT. 2004; 74: S128-S128.
Web of Science
** Roth, M; Fahrleitner, A; Piswanger-Solkner, CJ; Obermayer-Pietsch, B; Tiran, A; Leb, G; Dobnig, H
A calcium-raising mechanism lowers PTH levels and bone turnover with preservation of bone mass indices in institutionalized elderly at high risk of fracture
OSTEOPOROSIS INT 2004 15: S126-S126.
Web of Science
** Roth, M; Fahrleitner, A; Piswanger-Solkner, CJ; Obermayer-Pietsch, B; Tiran, A; Leb, G; Maier, E; Dobnig, H
Institutionalized elderly type II diabetics have higher bone mass, lower bone turnover markers and PTH levels compared to non-diabetics: Evidence for decreased calcium sensing by parathyroid glands.
J BONE MINER RES 2004 19: S439-S439.
Web of Science
2003
Full paper/article (Journal)
** Fahrleitner, A; Prenner, G; Leb, G; Tscheliessnigg, KH; Piswanger-Sölkner, C; Obermayer-Pietsch, B; Portugaller, HR; Berghold, A; Dobnig, H
Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation.
Bone. 2003; 32(1):96-106
Doi: 10.1016%2FS8756-3282%2802%2900926-2
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fahrleitner-Pammer, A; Dobnig, H; Piswanger-Soelkner, C; Bonelli, C; Dimai, HP; Leb, G; Obermayer-Pietsch, B
Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status.
Wien Klin Wochenschr. 2003; 115(9):291-297
Doi: 10.1007/BF03040334
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Hermann, J; Mueller, T; Fahrleitner, A; Dimai, HP
Early onset and effective inhibition of bone resorption in patients with rheumatoid arthritis treated with the tumour necrosis factor alpha antibody infliximab.
CLIN EXP RHEUMATOL 2003 21: 473-476.
Web of Science
PubMed
** Obermayer-Pietsch, BM; Lange, U; Tauber, G; Frühauf, G; Fahrleitner, A; Dobnig, H; Hermann, J; Aglas, F; Teichmann, J; Neeck, G; Leb, G
Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis.
Osteoporos Int. 2003; 14(12):995-1000
Doi: 10.1007/s00198-003-1501-5
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Bonelli, CM; Walter, D; Fahrleitner, A; Solkner, CP; Dobnig, H; Linhart, W; Reitinger, T; Windhager, R; Leb, G; Obermayer-Pietsch, B
Congenital hip dysplasia and disturbances of bone and connective tissue in adult female patients
BONE 2003 33: S13-S13.
Web of Science
** Dimai, HP; Piswanger-Soelkner, C; Fahrleitner, A; Ramschak-Schwarzer, S; Wenisch, H; Gugatschka, M; Leb, G
Is bone metabolism affected by the human thyroid stimulating hormone TSH? Preliminary results from a clinical study in patients with TSH-suppressive thyroid hormone therapy
BONE 2003 33: S13-S13.
Web of Science
** Obermayer-Pietsch, BM; Bonelli, CM; Walter, DE; Kuhn, RJ; Fahrleitner-Pammer, A; Berghold, A; Goessler, W; Stepan, V; Dobnig, H; Renner, W; Leb, G
Genetic disposition for adult lactose intolerance, calcium metabolism, bone density, and bone fractures
BONE 2003 33: S12-S12.
Web of Science
** Roth, M; Fahrleitner, A; Piswanger-Solkner, C; Obermayer-Pietsch, B; Leb, G; Dobnig, H
Diabetes mellitus in institutionalized patients is associated with higher bone mass measured by ultrasonography as well as lower iPTH levels and markers of bone turnover
BONE 2003 33: S14-S14.
Web of Science
2002
Full paper/article (Journal)
** Fahrleitner, A; Dobnig, H; Obernosterer, A; Pilger, E; Leb, G; Weber, K; Kudlacek, S; Obermayer-Pietsch, BM
Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease.
J Gen Intern Med. 2002; 17(9):663-669
Doi: 10.1046/j.1525-1497.2002.11033.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fahrleitner, A; Prenner, G; Kniepeiss, D; Iberer, F; Tscheliessnigg, KH; Piswanger-Sölkner, C; Obermayer-Pietsch, B; Leb, G; Dobnig, H
Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Wien Klin Wochenschr. 2002; 114(15-16):717-724
Web of Science
PubMed
Google Scholar
Abstract (Journal)
** Bonelli, CM; Walter, D; Fahrleitner, A; Piswanger-Solkner, CJ; Dobnig, H; Linhart, W; Reitinger, T; Windhager, R; Leb, G; Obermayer-Pietsch, BM
Congenital hip dysplasia and disturbances of bone and connective tissue in adult female patients
OSTEOPOROSIS INT 2002 13: S61-S61.
Web of Science
** Dimai, HP; Mueller, T; Fahrleitner, A; Hermann, J
Secondary osteoporosis in rheumatoid arthritis: Early onset and effective inhibition of bone resorption after a single infusion of the TNF-alpha antibody infliximab
OSTEOPOROSIS INT 2002 13: S25-S26.
Web of Science
** Dimai, HP; Mueller, T; Fahrleitner, A; Hermann, J
A single infusion of the tumor necrosis factor-alpha antibody infliximab suppresses bone resorption in patients with rheumatoid arthritis.
J BONE MINER RES. 2002; 17: S274-S275.
Web of Science
** Dobnig, H; Fahrleitner, A; Piswanger-Solkner, CJ; Obermayer-Pietsch, B; Leb, G
Prospective evaluation of hip-fracture risk in institutionalized elderly by measurement of ultrasonic velocity at the radius and phalanx.
J BONE MINER RES 2002 17: S188-S188.
Web of Science
** Fahrleitner, A; Dobnig, H; Leb, G; Dimai, HP; Piswanger-Solkner, C; Bonelli, CM; Obermayer-Pietsch, B
Osteoprotegerin serum levels in women: Influence of age, bone mass, bone turnover and fracture status
OSTEOPOROSIS INT 2002 13: S52-S52.
Web of Science
** Fahrleitner, A; Hofbauer, LC; Viereck, V; Obermayer-Pietsch, B; Leb, G; Dobnig, H
Serum osteoprotegerin-level as a novel independent predictor of BMD changes after initiation of bisphosphonate treatment in osteoporotic patients
OSTEOPOROSIS INT 2002 13: S12-S12.
Web of Science
** Fahrleitner, A; Lauermann, T; Schreiber, B; Lewitschnig, S; Leb, G; Obermayer-Pietsch, B; Dobnig, H; Klima, G
Intravenous ibandronate 1 mg every three months is an effective and well tolerated treatment option in patients with osteoporosis
OSTEOPOROSIS INT 2002 13: P42-P42.
Web of Science
** Fahrleitner, A; Prenner, G; Tscheliessnigg, KH; Leb, G; Piswanger-Solkner, CJ; Obermayer-Pietsch, B; Dimai, HP; Dobnig, H
Testosterone supplementation has additional benefits on bone metabolism in cardiac transplant recipients receiving intravenous bisphosphonate treatment: A prospective study.
J BONE MINER RES 2002 17: SU423-SU423.
Web of Science
** Obermayer-Pietsch, BM; Li, W; Fahrleitner, A; Piswanger-Solkner, CJ; Bonelli, CM; Leb, G; Dobnig, H
Polymorphisms of the vitamin D receptor and the collagen I alpha 1 genes as genetic risk factors for bone fractures in a high risk population in Austrian nursing homes
OSTEOPOROSIS INT 2002 13: S64-S64.
Web of Science
2001
Full paper/article (Journal)
** Neer, RM; Arnaud, CD; Zanchetta, JR; Prince, R; Gaich, GA; Reginster, JY; Hodsman, AB; Eriksen, EF; Ish-Shalom, S; Genant, HK; Wang, O; Mitlak, BH (Study group members, Leb, G; Dobnig, H; Fahrleitner, A)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
N ENGL J MED. 2001; 344(19): 1434-1441.
Doi: 10.1056%2FNEJM200105103441904
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Bonelli, CM; Fahrleitner, A; Walter, D; Stepan, V; Piswanger-Solkner, CJ; Dobnig, H; Leb, G; Obermayer-Pietsch, B
Osteoporosis and bone metabolism in premenopausal patients with congenital hip dysplasia
BONE 2001 28: S191-S191.
Web of Science
** Dobnig, H; Fahrleitner, A; Prenner, G; Tscheliessnig, KH; Piswanger-Solkner, C; Leb, G
Serum osteoprotegerin is a major determinant of bone density and vertebral fracture status in patients after cardiac transplantation
BONE 2001 28: S97-S97.
Web of Science
** Fahrleitner, A; Obernosterer, A; Pilger, E; Kudlacek, S; Hoffmann, A; Weber, K; Obermayer-Pietsch, B; Leb, G; Dobnig, H
High prevalence of vitamin D deficiency and low bone mass in patients with advanced peripheral arterial occlusive disease
BONE 2001 28: S210-S210.
Web of Science
** Fahrleitner, A; Prenner, G; Leb, G; Tscheliessnigg, K; Piswanger-Solkner, C; Dobnig, H
Combination therapy with ibandronate and calcitriol is effective in patients following liver transplantation.
J BONE MINER RES 2001 16: S287-S287.
Web of Science
** Mueller, TJ; Hermann, J; Fahrleitner, A; Yazdani-Biuki, B; Dimai, HP
Effects of the anti-TNF-antibody infliximab on markers of bone turnover in patients with rheumatoid arthritis.
ARTHRITIS RHEUM. 2001; 44(9): S232-S232.
Web of Science
** Obermayer-Pietsch, B; Walter, D; Fahrleitner, A; Stepan, V; Kotschan, S; Berghold, A; Leb, G
Bone mineral density, fracture status, bone metabolism and genetic background of osteoporosis in 350 mother-daughter pairs
BONE 2001 28: S191-S192.
Web of Science
2000
Abstract (Journal)
** Fahrleitner, A; Prenner, G; Kniepeiss, D; Tscheliessnigg, KH; Stach, L; Piswanger-Solkner, C; Leb, G; Dobnig, H
Evidence for continued bone loss after cardiac transplantation - A cross sectional study in 53 patients
OSTEOPOROSIS INT 2000 11: 379-379.
Web of Science
** Fruhwald, FM; Fahrleitner, A; Maier, R; Watzinger, N; Klein, W
Long-term treatment of pulmonary hypertension with inhaled iloprost and its effect on natriuretic peptides
EUR HEART J 2000 21: 596-596.
Web of Science
** Piswanger, CJ; Fahrleitner, A; Prenner, G; Kniepeiss, D; Tscheliessnigg, KH; Leb, G; Dobnig, H
Liver transplantation and prevalence of osteoporosis and secondary hyperparathyroidism: First observations on osteoprotective treatment.
J BONE MINER RES 2000 15: S430-S430.
Web of Science
1999
Full paper/article (Journal)
** Fruhwald, FM; Fahrleitner, A; Watzinger, N; Dobnig, H; Schumacher, M; Maier, R; Zweiker, R; Leb, G; Klein, W
N-terminal proatrial natriuretic peptide correlates with systolic dysfunction and left ventricular filling pattern in patients with idiopathic dilated cardiomyopathy.
Heart. 1999; 82(5):630-633
Doi: 10.1136/hrt.82.5.630
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fruhwald, FM; Fahrleitner, A; Watzinger, N; Fruhwald, S; Dobnig, H; Schumacher, M; Maier, R; Zweiker, R; Klein, WW
Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy.
Eur Heart J. 1999; 20(19):1415-1423
Doi: 10.1053/euhj.1999.1633
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Dobnig, H; Friedl, G; Piswanger-Solkner, C; Berghold, A; Scherubel, C; Fahrleitner, A; Obermayer-Pietsch, B; Leb, G
SOS-HIP study: Design of a 3-year hip-fracture prevention trial in institutionalized high-risk patients using ibandronate, calcium and vitamin D.
J BONE MINER RES. 14: 298-298.
Web of Science
** Fahrleitner, A; Prenner, G; Kniepeiss, D; Tscheliessnigg, KH; Dimai, HP; Leb, G; Dobnig, H
Influence of cardiac transplantation (CTX) on laboratory parameters, bone mineral density (BMD) and vertebral fracture rate.
J BONE MINER RES 1999 14: S389-S389.
Web of Science
** Friedl, G; Roth, M; Timischl, C; Fahrleitner, A; Obermayer-Pietsch, B; Leb, G; Dobnig, H
The effect of age on the response of bone to parathyroid hormone in rats.
J BONE MINER RES 1999 14: S308-S308.
Web of Science